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II Summary 	  
Nuclear transcription in eukaryotes is carried out by three multisubunit RNA 
polymerases, called Pol I, Pol II, and Pol III. Whereas Pol II transcribes mostly 
protein coding genes, Pol I and Pol III synthesize ribosomal RNA (rRNA) and 
transfer RNA (tRNA), respectively. Pol I transcription is the first step in the 
biogenesis of ribosomes, the cellular factories for protein synthesis. While the 
structure of Pol II has been studied in detail, structural information is still 
limited for Pol I. 
In this thesis different techniques were applied to investigate structural 
features of Pol I. As structure solution by X-ray crystallography was impaired 
by a highly complex non-crystallographic symmetry, other methods had to be 
employed in order to gain structural information on Pol I. After analysis by 
cryo-EM had established an overall view of Pol I, several questions on the 
domain architecture remained open. These were addressed by a novel 
method, combining protein-protein crosslinking and mass spectrometry. 
These experiments revealed that subunit A12.2, which shares homologies 
with Rpb9 as well as with TFIIS, is located in the pore and thus complements 
the active site of Pol I in order to induce strong intrinsic cleavage activity. Also 
the position of the A49/34.5 dimerization module and the A49 tWH domain 
could be revealed. The dimerization module is located on the polymerase 
lobe, similar to the position of the TFIIF on Pol II. The A49 tWH domain 
resides above the central cleft of the enzyme and resembles parts of TFIIE. 
Crosslinking-MS experiments with Pol III support these findings, since the 
C37/53 dimerization module, which is homologous to that of A49/34.5, could 
be located at a similar position on the lobe, and C34, the TFIIE homolog in Pol 
III, could be positioned in a region similar to that of the A49 tWH domain. 
These findings indicate that Pol I, and also Pol III, are distantly related to a Pol 
II-TFIIS-TFIIF-TFIIE complex. 	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1 Introduction 	  
1.1 Transcription systems in eukaryotes 	  
1.1.1 Eukaryotic RNA polymerases 	  
Nuclear transcription in eukaryotic cells is catalyzed by the three RNA 
polymerases (Pols) I, II and III. In Saccharomyces cerevisiae Pol I, II and III 
comprise 14, 12 and 17 subunits, respectively, and have a total molecular 
weight of 589 kDa, 514 kDa and 693 kDa, respectively (Cramer et al., 2008) 
(Table 1). 
 
Table 1. Subunit composition of RNA polymerases in S. cerevisiae 
 Pol I MW Pol II Pol III  
10 subunit core A190 
 
186.4 kDa Rpb1 C160 homolog 
 A135 
 
135.7 kDa Rpb2 C128 homolog 
 AC40 
 
37.7 kDa Rpb3 AC40 homolog 
 AC19 
 
16.2 kDa Rpb11 AC19 homolog 
 A12.2 
 
13.7 kDa Rpb9 C11 homolog 
 Rpb5 
(ABC27) 
25.1 kDa Rpb5 Rpb5 
(ABC27) 
common 
 Rpb6 
(ABC23) 
17.9 kDa Rpb6 Rpb6 
(ABC23) 
common 
 Rpb8 
ABC14.5 
16.5 kDa Rpb8 Rpb8 
ABC14.5 
common 
 Rpb10 
(ABC10α) 
8,3 kDa Rpb10 Rpb10 
(ABC10α) 
common 
 Rpb12 
(ABC10β) 
7.7 kDa Rpb12 Rpb12 
(ABC10β) 
common 
Subcomplex 
A14/43 
A14 14,6 kDa Rpb4 C17 counterpart 
 A43 
 
36.2 kDa Rpb7 C25 counterpart 
Subcomplex 
A49/34.5 
A49 46.7 kDa  C37 specific 
 A34.5 26.9 kDa  C53 
 
specific 
    C82 
 
specific 
    C34 
 
specific 
    C31 specific 
Total 14 subunits 589.6 kDa 12 subunits 17 subunits  
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RNA polymerase II transcribes all protein coding genes (Cramer, 2004), as 
well as many small RNAs that are involved in regulation of other genes 
through various mechanisms (Dye et al., 2006).  
RNA polymerase III is involved in transcription of small non-translated RNA 
molecules such as the 5S ribosomal RNA (rRNA), transfer RNA (tRNA), 7SL 
RNA (an essential component of the signal-recognition particle) and RNA 
molecules required for post-transcriptional processing of rRNA, mRNA and 
tRNA. Additionally, Pol III synthesizes short interspersed nuclear elements 
(SINES) including for example Alu genes in human (Geiduschek and 
Kassavetis, 2001). 
Pol I, however, exclusively synthesizes rRNA. In S. cerevisiae rRNA is 
transcribed as a precursor-rRNA, the 35S rRNA, which is then subsequently 
processed into 25S, 5.8S and 18S rRNA. These rRNAs are part of native 
ribosomes. 
All three polymerases comprise five identical subunits namely Rpb5, Rpb6, 
Rpb8, Rpb10, and Rpb12 as well as the five subunits homologous to Rpb1, 
Rpb2, Rpb3, Rpb9 and Rpb11. The Rpb4/7 heterodimer at the periphery of 
Pol II, which is not part of the core enzyme, shares homologies with the 
subcomplexes A14/43 and C17/25 in Pol I and III, respectively (Geiger et al., 
2008; Jasiak et al., 2006; Kuhn et al., 2007). 
 
1.1.2 Specific subunits in Pol I and Pol III 	  
For Pol II-dependent transcription the general transcription factors (GTFs) 
TFIIA, -B, -D, -E, -F and –H are essential (Table 2). Relationships between 
those GTFs and specific subunits are rare and could so far only be observed 
for TFIIF. All three eukaryotic polymerases consist of a 10-subunit core and a 
differing number of additional specific subunits (Table 1). Pol I and Pol III 
contain the peripheral heterodimers A14/43 and C17/25, respectively, which 
have been shown to be related to the Rpb4/7 subcomplex in Pol II (Geiger et 
al., 2008; Jasiak et al., 2006; Kuhn et al., 2007; Meka et al., 2003). For Pol I it 
has been shown that subunit A43 is essential for the interaction with the Pol I 
initiation factor Rrn3 and thus important for recruiting Pol I to the rDNA 
promoter (Milkereit and Tschochner, 1998; Peyroche et al., 2000). 
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Additionally, Pol I contains the specific subunits A49 and A34.5. Recent 
studies have shown that the N-termini of those subunits form a TFIIF-like 
dimerization module (Geiger et al., 2010). Furthermore, it was shown that 
A34.5 stabilizes A49 on Pol I and genetically interacts with DNA 
topoisomerase I (Gadal et al., 1997). Subunit A49 was shown to be important 
for Pol I activity (Huet et al., 1975; Liljelund et al., 1992), promoter dependent 
transcription (Hanada et al., 1996) as well as for recruiting Pol I and Rrn3 to 
the rDNA promoter (Beckouet et al., 2008). 
 
Table 2. General transcription factors in Pol II and known homologies to other 
transcription systems (Geiger et al., 2010; Hahn, 2004; Wang and Roeder, 1997). 
GTF Pol II Subunits Pol I 
homolog 
Pol III 
homolog 
Function 
TFIIA 2   stabilizes TBP and TFIID-DNA binding; 
blocks transcription inhibitors; positive and 
negative gene regulation  
TFIIB 1  Brf1 binds TBP, Pol II and promoter DNA; 
transcription start site selection 
TFIID/TBP 10-16 TBP TBP binds TATA-element and deforms promoter 
DNA; assembly platform for TFIIB and TFIIA 
TFIIE 2 A49-C-
term 
C34 binds promoter; may help to open or 
stabilize transcription bubble in open 
complex 
TFIIF 3 A49-N-
term 
A34.5-N-
term 
C37 
C53 
recruitment to PIC; open complex formation 
TFIIS 1  C11 stimulates intrinsic cleavage activity and 
allows for backtracking 
TFIIH 10   ATPase/helicase necessary for promoter 
opening and clearance; helicase for 
transcription coupled DNA repair; kinase 
activity for phosphorylation of Pol II CTD; 
transition from initiation to elongation 
 
Apart from the Rpb4/7 homolog C17/C25, Pol III contains five specific 
subunits which are organized in two subcomplexes C53/37 (Landrieux et al., 
2006) and C82/34/31 (Wang and Roeder, 1997). The subunits C53/37 have 
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been shown to adopt positions on the Pol III surface similar to that of TFIIF in 
the Pol II transcription machinery (Wu et al., 2011) and to play a role in 
promoter opening (Kassavetis et al., 2010). The trimeric subcomplex 
C82/34/31 was shown to interact with TFIIB and to play different roles in 
transcription initiation (Brun et al., 1997; Wang and Roeder, 1997). 
 
1.1.3 Structural information on eukaryotic polymerases and GTFs 	  
Most advances in understanding the molecular basis of transcription have 
been made in the Pol II system. Several structures of Pol II have been solved 
in the past ten years starting with the atomic models of the 10-subunit Pol II 
(Cramer et al., 2001) and the full 12-subunit enzyme (Armache et al., 2005). 
In addition, structures of Pol II together with its transcription factors IIB and IIS 
could be solved (Kettenberger et al., 2003; Kostrewa et al., 2009) (Fig. 1B). 
The overall architecture of Pol III has been determined by cryo-electron 
microscopy and native mass spectrometry (Fernandez-Tornero et al., 2010; 
Fernandez-Tornero et al., 2007; Lorenzen et al., 2007; Vannini et al., 2010) 
(Fig. 1C). Furthermore, a homology model was constructed based on the Pol 
II structure (Jasiak et al., 2006) and the structure of the C17/25 subcomplex 
was solved by X-ray crystallography (Jasiak et al., 2006). The structure of the 
human homolog of the Pol III specific subunit C82 was solved by X-ray 
crystallography (Lefevre et al., 2011). 
 
 
Figure 1. Current structural models of eukaryotic RNA polymerases. (A) EM model of 
Pol I with fitted Pol II structure (De Carlo et al., 2003). (B) X-ray structure of Pol II in complex 
with TFIIS (Cheung and Cramer, 2011). (C) Structural model of Pol III obtained based on 
cryo-EM analysis and homology modeling (Vannini et al., 2010). 
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First structural insights to Pol I were derived by EM analysis of two-
dimensional Pol I crystals (Schultz et al., 1993). Later cryo-EM studies 
resulted in 3D reconstructions at 34 Å resolution and visualized the A14/43 
containing stalk as well as densities for the Pol I-specific subunits A49 and 
A34.5 over the central cleft of the enzyme (Bischler et al., 2002; Peyroche et 
al., 2002). Different results were obtained by EM analysis using negative 
staining at 22 Å. This analysis confirmed the stalk density but not the location 
of A49 and A34.5 (De Carlo et al., 2003) (Fig. 1A). The atomic structure of the 
Rpb4/7 homolog A14/43 in Pol I was solved, confirming its relationship to 
Rpb4/7 (Geiger et al., 2008). The structural relationship of the specific 
subunits A49 and A34.5 to parts of the general transcription factors TFIIF and 
TFIIE was highlighted by X-ray crystallography (Geiger et al., 2010). 
 
1.2 Transcription of rDNA and ribosome biogenesis 
1.2.1 rRNA in ribosomes 	  
Ribosomes are one of the cell’s most complex molecular machines. Their 
importance for cell growth and proliferation arises from their central role in 
protein biosynthesis. Today’s ribosomes most likely evolved from early 
protoribosomes that comprised only RNA (Poole et al., 1998). Eukaryotic 
ribosomes contain about two-thirds RNA and one-third ribosomal protein and 
the formation of peptide bonds is mostly catalyzed by ribosomal RNA. Thus 
rRNAs, the transcripion products of RNA polymerase I and III, are the major 
architectural and catalytic components of the ribosome. 
The eukaryotic ribosome comprises a molecular mass of about 4 MDa. The 
large 60S ribosomal subunit comprises the 25S, 5.8S and 5S rRNA and the 
small 40S subunit contains the 18S rRNA. The 35S precursor for the 28S and 
5.8S rRNA is synthesized by Pol I. Pol III, however, synthesizes the precursor 
of the 5S rRNA. In addition to the rRNA about 80 ribosomal proteins are part 
of a functional ribosome, of which in yeast 46 build up the large ribosomal 
subunit and 32 are located within the small subunit. The maturation of rRNA 
and thus the ribosome biogenesis involves several intermediate steps and 
requires a vast number of trans-acting factors (Henras et al., 2008). Since 
building ribosomes requires the combined action of all three RNA 
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polymerases to produce the necessary RNAs and ribosomal proteins, 
ribosome biogenesis is the most energy and resource-consuming process in 
living cells. In growing cells transcription of rRNA by Pol I accounts for up to 
60% of total transcription (Warner, 1999). As a consequence of this high 
synthetic effort by the Pol I transcription machinery, rRNA synthesis is a 
central target for the regulation of metabolism and cell growth (Grummt, 
2003). The effect of tumor suppressors and oncogenes on ribosome 
biogenesis (Fontoura et al., 1997; Moss et al., 2007) and the role of Pol I and 
Pol III in cancer development (White, 2005) identified the rDNA transcription 
machinery as a target for cancer treatment (Drygin et al., 2011; Drygin et al., 
2010). 
 
1.2.2 Structure of the nucleolus and organization of ribosomal DNA loci 	  
Synthesis, processing and early stages of ribosome assembly take place in 
the largest subnuclear compartment, the nucleolus (Fig. 2A), which is formed 
during transcription of rRNA genes (Nomura, 2001). The initial assembly of 
ribosomes occurs co-transcriptionally and can be visualized as ‘Miller 
spreads’ on electron micrographs (Fig. 2B). 
 
 
Figure 2. Structure of the nucleolus and actively transcribed rDNA genes. (A) EM image 
of a yeast nucleolus (Trumtel et al., 2000). Visible nucleolar elements are fibrillar center (FC), 
granular center (GC) and dense fibrillar center (DFC). (B) ‘Miller spread’ of a single rDNA 
repeat. The promoter and terminator regions are labeled with P and T, respectively. Nascent 
rRNA is indicated with an arrow and black globules at the end of rRNAs mark pre-ribosomes 
(Russell and Zomerdijk, 2005). 
 
In S.cerevisiae, the rDNA locus contains approximately 150 head-to-tail 
repeats of the rRNA gene. Besides the coding regions, each gene contains a 
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5’ and 3’ external transcribed spacer (ETS) as well as two internal transcribed 
spacers (ITS). These spacer regions harbor cleavage sites important for 
further processing to mature rRNA (Fromont-Racine et al., 2003) (Fig. 3A). 
Furthermore, the rDNA locus comprises intergenic spacers (IGS). These 
spacers are important for efficient pre-rRNA synthesis as well as for rDNA 
silencing (Moss et al., 2007). The IGS regions contain multiple important 
sequence elements such as the rDNA promoter, enhancers, the spacer 
promoter and several terminator elements (Fig. 3B). Interestingly, studies on a 
yeast strain defective for Pol I transcription showed that neither Pol I nor 
tandemly arranged rDNA repeats are basal requirements for synthesis of 
rRNA. This study showed that Pol II could also synthesize rRNA from a high 
copy plasmid containing the 35S rDNA under control of the GAL7 promoter 
(Nogi et al., 1991). 
 
 
Figure 3. Ribosomal DNA locus of S. cerevisiae. (A) Single rDNA gene. External and 
internal transcribed spacers, the coding sequences for 18S, 5.8S and 25S rRNA as well as 
cleavage sites for rRNA processing are shown (Fromont-Racine et al., 2003). (B) Coding 
sequences are separated by intergenic spacers (IGS). IGS components are terminators 
(Term), enhancers, spacer promoter (SP), proximal terminator (PT), the upstream promoter 
element (UPE/UE) and the promoter core element (CORE/CE) with the ribosomal initiator 
(rInr). Sites for initiation are indicated by arrows or tis (Paule and White, 2000). 
 
1.2.3 Epigenetics of rRNA genes 	  
The number of rDNA repeat loci is variable between different species. 
Whereas S. cerevisiae has only one rDNA repeat locus on the right arm of 
chromosome XII (Venema and Tollervey, 1999), human and mouse possess 
five of those clusters on the short arms of different chromosomes (McStay 
and Grummt, 2008). Since each cluster is capable of forming a nucleolus, 
when its rRNA genes are actively transcribed, these regions are referred to as 
nucleolar organizer regions (NORs) (Nomura, 2001). EM studies revealed that 
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in exponentially growing yeast cells only half of the rDNA repeats are 
transcriptionally active (French et al., 2003). The creation of yeast strains 
comprising different numbers of rDNA repeats, however, revealed that the 
regulation of rDNA transcription is rather dependent on the Pol I loading rate 
than on the number of active genes (French et al., 2003). Activation and 
repression of rDNA is mediated by changes in DNA methylation and histone 
modification (Preuss and Pikaard, 2007). The epigenetic marks that 
characterize active, euchromatic, and rather inactive heterochromatic rDNA 
are similar to protein coding genes. The active chromatin state is 
characterized by DNA hypomethylation, histone H4 acetylation, and histone 
H3 dimethylation (H3K4me2), whereas the silenced state is marked by CpG 
methylation, histone H4 hypoacetylation, and H3K9 metyhlation (Earley et al., 
2006; Lawrence et al., 2004). rDNA silencing requires sense or antisense 
transcripts of the non-coding intergenic spacer (IGS) (Bierhoff et al., 2010; 
Mayer et al., 2006). The produced non-coding RNA is processed and 
incorporated into the nucleolar remodeling complex (NoRC), which then 
associates with rDNA, dependent on the transcription termination factor I 
(TTF-I) (Grummt, 2007; Langst et al., 1997; Santoro et al., 2002). Activation of 
rDNA transcription requires ATP-dependent chromatin remodeling through 
CSB (Cockayne Syndrome protein B), a SWI/SNF2-like DNA-dependent 
ATPase, and WSTF (William syndrome transcription factor) (Bradsher et al., 
2002; Felle et al., 2010). Disturbance of these epigenetic states is associated 
with alterations in the rRNA synthesis rates and genomic stability. It has been 
shown that overexpression of rRNA and thus excessive protein synthesis 
might be an initial step in malignant growth (Grummt, 2007; Ruggero and 
Pandolfi, 2003). In turn, inhibition of rDNA transcription can induce the cell’s 
apoptotic program, which might make Pol I transcription an important target 
for cancer treatment (Drygin et al., 2010). 
 
1.2.4 The Pol I transcription cycle 	  
In yeast and vertebrates, the rDNA promoter is a sequence of about 140-160 
base pairs (Moss et al., 2007) (Figure 4). The Pol I promoter is only poorly 
conserved between species consistent with the extreme species specificity of 
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the rDNA transcription machinery. Despite the low sequence conservation, 
most Pol I promoters contain two sequence elements namely the upstream 
promoter element (UPE/UE) and the core element (CE) (Boukhgalter et al., 
2002; Hamada et al., 2001; Moss et al., 2007). 
 
 
Figure 4. Structure of Pol I promoters. Sequences are aligned to the transcription initiation 
site (+1). Sites of functional importance are colored blue and sites that were shown to interact 
with the TBPI complex (SL-1, TIF-IB), UBF or TBP are indicated graphically. Aligned 
sequences are from Homo sapiens (Hs), Mus musculus (Mm), Rattus norvegicus (Rn), 
Xenopus laevis (Xl), Drosophila melanogaster (Dm), Drosophila virilis (Dv), Acanthamoeba 
castallanii (Ac), Arabidopsis thaliana (At), Saccharomyces cerevisiae (Sc) and 
Schizosaccharomyces pombe (Sp). Figure adapted from (Moss et al., 2007). 
 
The spatial arrangement of the promoter elements is a prerequisite for in vivo 
function, however the core element is mostly sufficient for correct transcription 
initiation in vitro. 
The formation of a pre-initiation complex (PIC) in all Pol I transcription 
systems requires the TATA box-binding protein (TBP) and a number of Pol I-
specific TATA-box associated factors (TAFs).  
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In mammals, the PIC comprises the upstream binding factor (UBF), selectivity 
factor 1 (SL1) or TIF-IB (Bell et al., 1988). UBF is a HMG-1 box protein with 
specific DNA binding capabilities and has been implicated in enhancement of 
Pol I transcription by formation of a putative enhancesosome (Bazett-Jones et 
al., 1994). The mammalian initiation factor SL1 comprises the subunits 
TAF1110/95, TAF168/63, TAF148, TAF141 and TBP (Comai et al., 1992; 
Gorski et al., 2007). Upon UBF binding at the promoter region SL1 is recruited 
through the C-terminal domain of UBF and a stable pre-initiation complex is 
formed (Tuan et al., 1999). 
 
 
Figure 5. The pre-initiation complex in S. cerevisiae. Assembly of the Pol I PIC. DNA is 
shown in red, promoter elements in yellow, UAF subunits are depicted in green and the CF is 
labeled in brown (Moss, 2004). 
 
The composition of the Pol I initiation complex in yeast shows major 
differences compared to the mammalian system (Figure 5). The upstream 
element of the yeast Pol I promoter is bound by the upstream activation factor 
(UAF) that comprises two histones H3 and H4, an uncharacterized protein 
UAF30 and the factors Rrn5, Rrn9 and Rrn10. The UAF interacts with TBP, 
the only component present in all eukaryotic transcription systems. After 
establishment of the UAF-UE complex, TBP is either already present or is 
recruited along with the CF (Aprikian et al., 2001; Lin et al., 1996; Steffan et 
al., 1996). The CF itself binds to the core element and comprises the subunits 
Rrn6, Rrn7 and Rrn11, which are homologous to TAF1110/95, TAF168/63 and 
TAF148, respectively. The interplay of TBP with the CF is mediated by its 
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interaction with Rrn7 and Rrn11 (Bordi et al., 2001; Keener et al., 1998; Lalo 
et al., 1996; Moss et al., 2007). For TAF141, the fourth human CF subunit, no 
homolog has been described so far. 
Once initiation is accomplished Pol I undergoes a transition to an elongating 
state. Pol I transcribes the 35S-precursor at a rate of 5-6 kb/min similar to 
elongation rates of Pol II (Darzacq et al., 2007; Dundr et al., 2002).  
Transcription termination occurs at the 3’ end of the transcribed region, 
between the IGS and the rDNA promoter (Figure 3B). Transcription 
termination requires TTF-I, which bends the T-rich termination site, leads to 
Pol I pausing and cooperation with the Pol I and transcript release factor 
PTRF and thus finally leads to dissociation of Pol I from the rDNA (Jansa and 
Grummt, 1999; Russell and Zomerdijk, 2005). 
 
1.2.5 Regulation of rDNA transcription  in vivo 	  
Transcription of rDNA by RNA polymerase I in eukaryotes is regulated on two 
levels. A first level of regulation is represented by the alteration of the number 
of active genes through epigenetic mechanisms (see Chapter 1.2.3). 
Secondly, transcription regulation can be achieved through different 
mechanisms that alter the rate of transcription in response to cellular signals. 
The regulation of initiation is mainly due to alterations in the phosphorylation 
pattern of the initiation factors Rrn3 and TIF-IA in yeast and mammals, 
respectively. The free form of the yeast initiation factor Rrn3 is mostly 
phosphorylated, whereas unphosphorylated Rrn3 stably binds to Pol I. 
Phosphorylation of specific sites on the Pol I surface seems to be a 
requirement for a stable association of Pol I and Rrn3 and thus efficient 
transcription initiation (Fath et al., 2001; Gerber et al., 2008). In addition an 
involvement of the target of rapamycin (TOR) kinase or kinases of the TOR 
signaling pathway seems plausible since rapamycin treatment decreases the 
amount of Pol I-Rrn3 complexes in vivo (Claypool et al., 2004). 
In mouse, TIF-IA phosphorylation is mainly regulated through mTOR nutrient 
sensing pathway (Proud, 2002) and the Jun N-terminal kinase pathway (JNK) 
(Mayer et al., 2005; Mayer et al., 2004). In mammals, the Raf-MEK-ERK 
kinase pathway is also involved in modulation of TIF-IA phosphorylation, thus 
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effecting the formation of the TIF-IA-Pol I complex (Zhao et al., 2003). As 
growth factors and kinase activation of rDNA transcription do not affect the 
absolute number of transcribing polymerases (Stefanovsky et al., 2006a), Pol 
I elongation has to be regulated as well. Indeed phosphorylation of two HMG1 
boxes of UBF, leading to remodeling of the potential enhancesome, facilitates 
transcription elongation (Stefanovsky et al., 2006b; Stefanovsky et al., 2001). 
Different splice variants have been recognized to be involved in differential 
regulation of transcription elongation by Pol I (Stefanovsky and Moss, 2008). 
 
1.2.6 Ribosome assembly 	  
Structures and function of mature cytoplasmic ribosomes of both, prokaryotes 
and eukaryotes have been extensively characterized (Ban et al., 2000; Ben-
Shem et al., 2010; Schuwirth et al., 2005). However, the assembly pathway 
resulting in fully functional ribosomes is only partly understood (Fatica and 
Tollervey, 2002; Kressler et al., 2010; Tschochner and Hurt, 2003) (Figure 6). 
The synthesis of 18S rRNA in yeast involves four successive cleavages by 
different endonucleases, while the processes leading to 25S and 5.8S rRNA 
involves a large number of processing and cleavage events conducted by 
endo- and exonucleases (Venema and Tollervey, 1999). Terminal knobs at 
the 5’ end of each 35S pre-rRNA, as seen in Miller spreads, indicate that 
rRNA processing starts co-transcriptionally (Miller and Beatty, 1969; Mougey 
et al., 1993) (Figure 2 B). These terminal knobs contain the nascent transcript 
and a number of small nucleolar ribonucleoprotein particles (snoRNPs), which 
catalyze modification reactions such as 2’-O-ribose methylation (Henras et al., 
2008). Additionally, a subset of small subunit ribosomal proteins (Rps) and 
non-ribosomal factors are involved in formation of the terminal knobs. Thus, 
the formation of the first pre-ribosomal particle, the 90S particle occurs co-
transcriptionally. The 90S particle is joined by additional S-proteins and 40S 
factors, which then initiate the separation of the 90S pre-ribosome into pre-
60S and pre 40S ribosomal subunits. The division of the 90S particle occurs 
through cleavage at U3 snoRNP-dependent sites (Grandi et al., 2002; Schafer 
et al., 2003). 
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Figure 6. Model for maturation and export of 40S and 60S ribosomal subunits. The 
earliest ribosomal precursor, the 90S particle, contains the 35S pre-rRNA the large U3 
snoRNP, part of the processome, and further 40S synthesis factors. Separation into pre-40S 
and pre-60S particles is followed by several maturation steps in the nucleus and export to the 
cytoplasm, where the final maturation steps take place. Factors involved in the different steps 
are graphically depicted. Export factors for 40S subunits are not known. (Tschochner and 
Hurt, 2003). 
 
Transport and maturation of pre-60S particles involves numerous non-
ribosomal factors, such as GTPases, RNA helicases, ATPases and different 
transport factors, that transiently interact with the pre-60S particle in time and 
compartment dependent manner (Tschochner and Hurt, 2003). In contrast, 
after separation, the pre-40S particle is accompanied by only a handful non-
ribosomal components such as methyltransferases and GTPases that are 
involved in 40S maturation (Gelperin et al., 2001; Lafontaine et al., 1995; 
Lafontaine et al., 1998). Nuclear export of immature ribosomal subunits is 
again assisted by different export factors like Xpo1/Crm1 and the Ran 
GTPase (Hurt et al., 1999; Moy and Silver, 1999, 2002; Trotta et al., 2003) 
and is followed by the release of those factors, which requires different 
proteins, such as the GTPases Efl1 and Lsg1, and marks the final stage in 
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maturation of the ribosomal subunits (Kressler et al., 2010; Senger et al., 
2001). 
 
1.3 Aim of this work 	  
In the past years several structures of Pol II and Pol II-specific general 
transcription factors have been solved (see Chapter 1.1.3). However, 
structural information for the Pol I transcription machinery is limited to partial 
structures of individual Pol I subcomplexes, namely A49/A34.5 and A14/43 
(see Chapter 1.1.3). Therefore, the aim of this work was to gain insights into 
the structure of the whole 14-subunit RNA polymerase I. Several techniques, 
such as X-ray crystallography, cryo-EM and chemical crosslinking and mass 
spectrometry, have been employed in this work to expand our knowledge on 
structural properties of Pol I. 
Insights into the architecture of this large, 590 kDa, macromolecular complex 
would possibly enable us to explain functional properties of the enzyme, 
which, in turn, could help to understand the structural basis of rDNA 
transcription and its regulation. Knowledge on structural details could also 
unravel possible evolutionary differences or similarities between the three 
different eukaryotic polymerase systems. The availability of structural 
information on Pol II and Pol I substructures was expected to facilitate the 
efforts of gaining new structural insights, especially for the structure solution 
by X-ray crystallography. 	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2 Materials and Methods 
 Materials 2.1	  
2.1.1 Bacterial and yeast strains 	  
Table 3. E. coli strains 
Name Description Source 
BL21-CodonPlus (DE3)-RIL E. coli B F– ompT hsdS(rB– mB–) dcm+ 
Tetr gal λ(DE3) endA Hte [argU ileY 
leuW Camr] 
 
Stratagene 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F’ proAB laclqZΔM15 
Tn10 (Tetr)] 
 
Stratagene 
NEB Turbo Competent E. 
coli (High Efficiency) 
 F´ proA+B+ lacIq ∆ lacZ M15/ fhuA2 
∆(lac-proAB) glnV gal R(zgb-
210::Tn10)TetS endA1 thi-1 ∆(hsdS-
mcrB)5 
New England 
Biolabs 
	  	  
Table 4. S.cerevisiae strains 
Name Description Source 
GPY2 leu2-Δ1 ade2-101 trp1-Δ63 ura3-52 his3-
Δ200 lys2-801 rpa43Δ::LEU2 pAS22 
(Trp1) (HA and 6-His tag) 
 
(Kuhn et al., 
2007) 
GPY2 ΔRPA34 leu2-Δ1 ade2-101 trp1-Δ63 ura3-52 his3-
Δ200 lys2-801 rpa34Δ::HIS3MX6 
rpa43Δ::LEU2 pAS22 (Trp1) (HA and 6-
His tag) 
 
(Kuhn et al., 
2007) 
GPY2 RPA12ΔC leu2-Δ1 ade2-101 trp1-Δ63 ura3-52 his3-
Δ200 lys2-801 rpa12Δ::KanMX 
rpa43Δ::LEU2 pAS22 (Trp1) (HA and 6-
His tag) pRS313-rpa12(1-234) 
(Kuhn et al., 
2007) 
 
2.1.2 Media 	  
Table 5. Media for E.coli cultivation 
Name Description 
LB 1 % (w/v) Bacto tryptone, 0.5 % (w/v) yeast extract, 8.6 mM NaCl, 2.6 mM NaOH, 
plates contained 1.5 % (w/v) agar 
 
ZY 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, used with 5052 and NPS 
 
SOB 2% (w/v) tryptone; 0.5% (w/v) yeast extract; 8.55 mM NaCl; 2.5 mM KCl; 10 mM 
MgCl2 
SOC SOB + 20 mM glucose1 
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Table 6. Additives for E.coli media 
Name Stock solution Applied concentration 
50 × 5052 25 % (w/v) glycerol, 2.5 % (w/v) 
glucose, 10 % (w/v) α-lactose 
0.5 % (w/v) glycerol, 0.05 % 
(w/v) glucose, 0.2 % (w/v) α-
lactose 
20 × NPS 0.5 M (NH4)2SO4, 1 M KH2PO4, 1 M 
Na2HPO4 
25 mM (NH4)2SO4, 50 mM 
KH2PO4, 50 mM Na2HPO4 
Ampicillin 30 mg/ml in H2O 
 
30 µg/ml  
Kanamycin 50 mg/ml in EtOH 
 
50 µg/ml  
Chloramphenicol 50 mg/ml in EtOH 
 
50 µg/ml  
Streptomycin 12.5 mg/ml in 70% EtOH 
 
12.5 µg/ml 
IPTG 1 M IPTG 0.5-1 mM IPTG 
 
 
Table 7. Media for S.cerevisiae cultivation 
Name Description 
YEP 1.5 % (w/v) yeast extract, 2 % (w/v) peptone 
 
YEPD 1.5 % (w/v) yeast extract, 2 % (w/v) peptone, 
2 % (w/v) glucose 
 
SC-Broth / 2% (w/v) glucose (Formedium) 0.69% (w/v) nitrogen base, 2% (w/v) 
glucose; pH 5.6-6.0 
 
CSM-Mix –His (Formedium) amino acid mix lacking histidine 
 
 
Table 8. Additives and components for S. cerevisiae media. 
Name Stock solution Applied concentration 
Ampicillin 100 mg/ml in H2O 
 
0.005% (w/v) ampicillin 
Tetracycline 12.5 mg/ml in 70% EtOH 
 
0.00125% (w/v) tetracycline 
Geneticin (G418) 200 mg/ml in H2O 200 µg/ml for yeast culture 
Nourseothricin 
(clonNAT) 
 
100 mg/ml in H2O 100 µg/ml for yeast culture 
Antifoam C emulsion 100% (v/v) antifoam C 
emulsion 
0.1% (v/v) antifoam C emulsion 
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2.1.3 Buffers, markers, solutions and enzymes 
 
Table 9.  General buffers, markers, dyes and solutions 
Name Description or source 
100 × PI 60 µM leupeptin, 200 µM pepstatin A, 98 mM PMSF, 
211 mM benzamidine; in EtOH 
4 × stacking gel buffer 0.5 M Tris-HCl, 0.4 % SDS (w/v), pH 6.8 
 
4 × separation gel buffer 3 M Tris-HCl, 0.4 % SDS (w/v), pH 8.85 
 
Tris-glycine running buffer 25 mM Tris, 250 mM glycine, 0.1 % (w/v) SDS 
 
MES running buffer 50 mM MES, 50 mM Tris, 0.1 % (w/v) SDS, 1 mM 
EDTA 
 
5 × SDS loading dye 25 % (v/v) glycerol, 7.5 % (w/v) SDS, 250 mM Tris-Cl 
(pH 6.8 at 20 °C), 0.5 % (w/v) bromophenol blue, 12.5 
% (v/v) β-mercaptoethanol 
1 × SDS loading dye 5 % (v/v) glycerol, 1.5 % (w/v) SDS, 50 mM Tris-Cl 
(pH 6.8 at 20 °C), 0.1 % (w/v) bromophenol blue, 2.5 
% (v/v) β-mercaptoethanol 
Broad range molecular weight 
marker 
Bio-Rad 
Coomassie stain 50 % (v/v) ethanol, 7 % (v/v) acetic acid, 0.125 % 
(w/v) Coomassie Brilliant Blue R-250 
Destain 7 % (v/v) acetic acid, 5 % (v/v) ethanol 
 
Ethidium bromide solution 1 % Roth 
 
SYBR Safe DNA gel stain, 10,000 
× concentrate in DMSO 
 
 
Invitrogen 
TBE 90 mM Tris, 90 mM boric acid, 2 mM EDTA (pH 8.0) 
 
6 × DNA loading dye Fermentas 
 
Gene Ruler 1 kb DNA ladder 0.1 
µg/µl 
Fermentas 
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Table 10. Buffers for Pol I purification 
Name Description 
Lysis/Freezing buffer 150 mM HEPES pH 7.8, 60 mM MgCl2, 30% (v/v)glycerol, 5 
mM DTT1, 1x PI1 
 
Dilution buffer 100 mM HEPES pH 7.8, 20 mM MgCl2, 400 mM (NH4)2SO4, 5 
mM DTT1, 1x PI1 
 
Dialysis buffer (2x) 100 mM potassium acetate (KOAc), 40 mM HEPES pH 7.8, 2 
mM MgCl2, 20% (v/v) glycerol, 10 mM β-mercaptoethanol1, 1x 
PI1 
 
Res/W1 buffer 1.5 M KOAc, 20 mM HEPES pH 7.8, 1 mM MgCl2, 10% (v/v) 
glycerol, 10 mM β-mercaptoethanol1, 0.5x PI1 
 
W2 buffer 300 mM KOAc, 20 mM HEPES pH 7.8, 1 mM MgCl2, 10% 
(v/v) glycerol, 10 mM β-mercaptoethanol1 
 
E100 buffer 300 mM KOAc, 20 mM HEPES pH 7.8, 1 mM MgCl2, 10% 
(v/v) glycerol, 100 mM imidazole, 10 mM β-mercaptoethanol1 
 
MonoQ buffer A 10% (v/v) glycerol, 1 mM MgCl2, 20 mM HEPES pH 7.8, 5 mM 
DTT1 
 
MonoQ buffer B 20 mM HEPES pH 7.8, 1 mM MgCl2, 10% (v/v) glycerol, 5 mM 
DTT1, 2 M KOAc 
 
MonoQ buffer C 20 mM HEPES pH7.8, 50 mM (NH4)2SO4, 2 M urea, 1 mM 
MgCl2, 10% (v/v) glycerol, 5 mM DTT1 
 
MonoQ buffer D 20 mM HEPES pH7.8, 1 M (NH4)2SO4, 1 mM MgCl2, 2 M urea, 
10% (v/v) glycerol, 5 mM DTT1 
 
Superose 6 buffer A 60 mM (NH4)2SO4, 5 mM HEPES pH 7.8, 1 mM MgCl2, 10 µM 
ZnCl2, 5mM DTT1 
 
Superose 6 buffer B 100 mM (NH4)2SO4, 20 mM HEPES pH 7.8, 1 mM MgCl2, 10 
µM ZnCl2, 5% (v/v) glycerol, 5 mM DTT1 
 
Superose 6 buffer C 20 mM HEPES pH 7.8, 1 mM MgCl2, 300 mM potassium 
acetate, 10% glycerol, and 5 mM DTT 
1 component added prior to usage 
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Table 11. Buffers for Pol III purification 
Name Description 
Buffer S500 200 mM Tris-HCl pH 8.0, 500 mM (NH4)2SO4, 10 mM MgCl2, 
10% (v/v) glycerol, 10 mM β-mercaptoethanol1, 1x PI1 
 
Buffer D0-resuspension 40 mM HEPES pH 7.8, 5 mM MgCl2, 10% (v/v) glycerol, 1 mM 
EDTA, 10 mM β-mercaptoethanol1, 1x PI1 
 
Buffer D0-Äkta 40 mM HEPES pH 7.8, 5 mM MgCl2, 10% (v/v) glycerol, 10 mM 
imidazole, 10 mM β-mercaptoethanol1, 1x PI1 
 
Buffer D200 40 mM Hepes pH 7.8, 5 mM MgCl2, 10% (v/v) glycerol, 200 mM 
KCl, 1 mM EDTA, 10 mM β-mercaptoethanol1, 1x PI1 
 
Buffer D1000 40 mM HEPES pH 7.8, 5 mM MgCl2, 10% (v/v) glycerol, 1M 
KCl, 10 mM β-mercaptoethanol1, 1x PI1 
 
Buffer D500+10i 40 mM HEPES pH 7.8, 5 mM MgCl2, 10% (v/v) glycerol, 10 mM 
imidazole, 500 mM KCl, 10 mM β-mercaptoethanol1, 1x PI1 
 
Buffer H250+10i 40 mM HEPES pH 7.8, 5 mM MgCl2, 10% (v/v) glycerol, 10 mM 
imidazole, 250 mM (NH4)2SO4 10 mM β-mercaptoethanol1, 1x PI1 
 
Buffer H250+250i 40 mM HEPES pH 7.8, 5 mM MgCl2, 10% (v/v) glycerol, 250 
mM imidazole, 250 mM (NH4)2SO4, 10 mM β-mercaptoethanol1, 
1x PI1 
 
Buffer H250 40 mM HEPES pH 7.8, 5 mM MgCl2, 250 mM (NH4)2SO4, 20% 
(v/v) glycerol, 0.5 mM EDTA, 10 mM β-mercaptoethanol1, 1x PI1 
 
Buffer H1000 40 mM HEPES pH 7.8, 5 mM MgCl2, 20% (v/v) glycerol, 0.5 mM 
EDTA, 1 M (NH4)2SO4, 10 mM β-mercaptoethanol1, 1x PI1 
 
MonoQ-0 40 mM Hepes pH 7.8, 5 mM MgCl2, 10% (v/v) glycerol, 5 mM 
DTT1 
 
MonoQ-1000 40 mM Hepes pH 7.8, 5 mM MgCl2, 10% (v/v) glycerol, 1 M 
(NH4)2SO4, 5 mM DTT1 
 
Pol III buffer 40 mM HEPES pH 7.8, 50 mM (NH4)2SO4, 100 µM MgCl2, 10 
µM ZnCl2, 5 mM DTT1 
 
Superose6KCl 40 mM HEPES pH 7.8, 120 mM KCl, 100 µM MgCl2, 10 µM 
ZnCl2, 5 mM DTT1 
1 component added prior to usage 
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Table 12. Buffers for A49/A34.5 purification 
Name Description 
Buffer A 300 mM NaCl, 50 mM Tris pH 7.5, 10 mM β-mercaptoethanol1, 
1x PI1 
 
Buffer B 1 M NaCl, 50 mM Tris pH 7.5, 10 mM β-mercaptoethanol1 
 
Buffer C 50 mM Tris pH 7.5, 10 mM β-mercaptoethanol1 
 
Buffer D 100 mM NaCl, 50 mM Tris pH 7.5, 5 mM DTT1 
1 component added prior to usage 
 
 
Table 13. Buffers for Rrn3 purification 
Name Description 
Buffer A 50 mM HEPES pH 7.8, 200 mM NaCl, 10% (v/v) glycerol, 3 mM 
DTT1 
 
Buffer B 50 mM HEPES pH 7.8, 10% (v/v) glycerol, 5 mM DTT1 
 
Buffer C 50 mM HEPES pH7.8, 300 mM NaCl, 5 mM DTT1 
1 component added prior to usage 
 
Table 14. Pol I crystallization solutions 
Name Description 
Pol I buffer 60 mM (NH4)2SO4, 5 mM HEPES pH 7.8, 1 mM MgCl2, 10 µM 
ZnCl2, 5mM DTT1 
 
Di-ammonium tartrate 
(mother solution) 
8.0, 8.5, 9.0, 9.5, 10.0% (w/v) PEG 6'000, 3% (v/v) MPD, 100 
mM HEPES pH 7.5, 300 mM Di-ammoniumtartrate, 3 mM TCEP 
 
Di-ammonium tartrate 
(cryo solution) 
9.0% (w/v) PEG 6'000, 3% (v/v) MPD, 100 mM HEPES pH 7.5, 
300 mM Di-ammoniumtartrate, 3 mM TCEP, 22% (v/v) PEG 400 
 
1 component added prior to usage 
 
 
Table 15. Buffers, solutions and components for in vitro RNA assays 
Name Description 
Transcription buffer 20 mM HEPES pH 7.6, 60 mM (NH4)2SO4, 8 mM MgSO4, 10 µM 
ZnCl2, 10% (v/v) glycerol, 10 mM DTT 
 
2x urea loading dye 180 mM Tris, 180 mM boric acid, 4 mM EDTA pH 8.0, 8 M urea, 
0.03% (w/v) bromophenol blue, 0.03% (w/v) xylene cyanol FF 
 
2x urea loading buffer 180 mM Tris, 180 mM boric acid, 4 mM EDTA pH 8.0, 8 M urea 
 
TBE 90 mM Tris, 90 mM boric acid, 2 mM EDTA pH 8.0 
 
Urea gel 10-20% acrylamide, 7 M urea, 1x TBE 
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Table 16. Buffers for mass spectrometry 
Name Description 
SEC mobile phase buffer 30% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid, 69.9 % 
(v/v) H2O 
 
C18 mobile phase buffer 3% (v/v) acetonitrile, 0.1% (v/v) formic acid, 96.9% (v/v) H2O 
 
 
 Methods 2.2	  
2.2.1 Protein expression and purification 	  
2.2.1.1 Purification of Pol I from S.cerevisiae 	  
Complete 14-subunit Pol I was purified from Saccharomyces cerevisiae strain 
GPY2 (leu2-Δ1 ade2-101 trp1-Δ63 ura3-52 his3-Δ200 lys2-801 
rpa43Δ::LEU2), carrying a pAS22 plasmid coding for a HA and hexahistidine 
tagged version of subunit A43. A 20 L fermenter was inoculated with culture 
from shaking flasks to a starting OD600 of approximately 0.2. Cells were grown 
for ≈ 8h at 30 °C to an OD600 of 1.5 – 2.0. The pre-culture was used for 
inoculation of a 200 L fermenter to a starting OD600 of 0.2. Fermentation was 
carried out over night at 30 °C until the cells reached an OD600 of 6-8. The 
cells were harvested at 20,000 rpm in a flow-through centrifuge (Padberg 
Z4IG) yielding approximately 2.0 – 2.5 kg of yeast cells. The pellet was 
resuspended in 500 ml freezing buffer per 1kg of cells and subsequently flash 
frozen in liquid nitrogen in 225 ml batches. 
For each purification, two 225 ml batches were thawed in warm water. 
Ammonium sulfate and PI was added resulting in final concentrations of 400 
mM and 1x, respectively. Bead beating was done using two beakers filled with 
200 ml glass beads each. The cells suspension was added to the pre-cooled 
glass beads and the beakers were filled up with dilution buffer in order to 
prevent the formation of foam during the process. Cell lysis was carried out for 
1.5 h at 4 °C in repetitive cycles of 30 s bead beating followed by 90 s cooling. 
The lysed cells were separated from the glass beads by filtration. Glass beads 
were washed with 50 – 100 ml dilution buffer. The lysate was centrifuged at 
8,000 g in a SLA-1500 rotor (Sorvall) for 30 min at 4 °C. The supernatant was 
subjected to ultracentrifugation at 30,000 g for 90 min in a SW28 
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ultracentrifuge rotor (Beckman) in order to obtain a whole cell extract. After 
removing the top fat layer, the supernatant was dialyzed overnight at 4 °C in 
40-50 ml batches against 2 L of 1x dialysis buffer. The dialyzed extract was 
centrifuged at 18,500 g for 90 min in a Ti45 rotor (Beckman). The resulting 
pellet was resuspended in Res/W1 buffer and incubated for 4 h with 8 ml pre-
equilibrated Ni-NTA agarose (Qiagen) on a turning wheel at 4 °C. The 
suspension was loaded into two gravity flow columns and washed with 5 CV 
Res/W1 and W2 buffer, respectively. Bound proteins were eluted with 25 ml 
buffer E100, resulting in 50 ml of total sample. For the ensuing anion 
exchange chromatography a MonoQ 10/100 column (GE Healthcare) was 
equilibrated with 15 % MonoQ buffer B. The sample was loaded at a 
concentration of 15 % buffer B and eluted with buffer B by applying a multi-
step gradient. Pol I containing fractions eluted at a concentration of ≈ 1.1 M 
KOAc (conductivity ≈ 49 mS/cm2). The Pol I containing fractions were pooled 
and diluted 5.5-fold with MonoQ buffer A to a final KOAc concentration of 200 
mM. For the final purification stage a MonoS 5/50 cation-exchange column 
(GE-Healthcare) was used, applying a gradient from 200 mM KOAc to 2 M 
KOAc with buffers A and B. Pol I eluted at a concentration of ≈ 490 mM KOAc 
(conductivity ≈ 49 mS/cm2). In order to remove glycerol and check the sample 
for monodispersity a size-exclusion chromatography was performed using 
Superose 6 buffer A and a Superose 6 10/300 GL column (GE Healthcare). 
For crosslinking experiments the final gelfiltration step was performed using 
Superose 6 buffer C. 
 
2.2.1.2 Preparation of Pol I ΔA49/A34.5 	  
Pol I lacking the specific subunits A49 and A34.5 was purified with the help of 
controlled urea dissociation. Therefor Pol I containing fractions after cation-
exchange chromatography were pooled and diluted 1:1 with 25% buffer B and 
dialyzed overnight against MonoQ buffer C. The dialyzed sample was 
subjected to an anion-exchange chromatography column (MonoQ 5/50 GL, 
GE Healthcare). Pol I ∆A49/34.5 was eluted applying a gradient from 50 mM 
to 1M (NH4)2SO4 using MonoQ buffer C and D. For removal of urea and 
glycerol Pol I ∆A49/34.5 was further purified by size-exclusion 
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chromatography using Superose 6 buffer B and a Superose 6 10/300 GL 
column (GE Healthcare).	  
2.2.1.3 Preparation of Pol I A12.2ΔC 	  
The Pol I variant lacking residues 79-125 of subunit A12.2 was fermented in 
synthetic dextrose complete (SDC) medium without histidine. The purification 
protocol is exactly the same as for wild-type Pol I except the final gelfiltration 
step was omitted. 
 
2.2.1.4 Preparation of Pol I in complex with Rrn3 	  
Purified Pol I was incubated overnight with a 9-fold molar excess of purified 
Rrn3. The resulting complex was finally purified by size-exclusion 
chromatography using a Superose 6 10/300 column (GE Healthcare) and 
Superose 6 buffer A containing 150 mM KOAc instead of (NH4)2SO4. 
 
2.2.1.5 Preparation of Rrn3 	  
Rrn3 from S. cerevisiae was cloned into pET28b using the NheI/HindIII 
restriction sites resulting in an N-terminall hexahistidine tag. The protein was 
expressed in E. coli BL21 (DE3) RIL cells (Stratagene). Expression was 
performed in auto-inducing medium (TB) for 16 h at 24°C. Cells were 
harvested, washed with PBS and lysed by sonication. The lysate was 
centrifuged and the supernatant was loaded onto a 1 ml gravity flow Ni-NTA 
column (BioRad, Qiagen) equillibrated with buffer A. The column was washed 
with 20 CV buffer A containing 20 mM imidazole, followed by washing steps 
with buffer A containing 30 mM and 50 mM imidazole. Bound proteins were 
eluted with buffer A containing 150 mM imidazole. Rrn3 was further purified 
by anion exchange chromatography using a MonoQ 5/50 column (GE 
Healthcare). The column was equilibrated buffer B and proteins were eluted 
applying a linear gradient from 100 mM to 1 M NaCl over 20 CV. After 
concentration, the sample was applied onto a Superdex 200 10/300 GL (GE 
Healthcare) size-exclusion chromatography column equilibrated with buffer C. 
Peak fractions were pooled and concentrated. 
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2.2.1.6 Preparation of recombinant A49/A34.5 	  
The genes for A49 and A34.5 were cloned sequentially into vector pET28b 
(Novagen), introducing a C-terminal hexahistidine tag on A49 and a second 
ribosomal binding site for bicistronic expression. The two subunits were 
coexpressed for 18 h at 18 °C in E. coli BL21 (DE3) RIL cells (Stratagene) in 
4 l of LB medium. Cells were harvested by centrifugation, resuspended in 100 
ml buffer A, and lysed by sonication. After centrifugation the supernatant was 
loaded onto a 3 ml Ni-NTA column equilibrated with buffer C. The column was 
washed stepwise with 15 ml of buffer B and 15 ml of buffer B containing 30 
mM imidazole. The A49/34.5 heterodimer was eluted with buffer B containing 
100 mM imidazole. Eluted fractions were diluted 3-fold with buffer C. A MonoS 
cation exchange column was equilibrated with buffer D, and proteins were 
eluted with a linear gradient of 18 column volumes from 100 mM to 1 M NaCl. 
A49/34.5 eluted at 280 mM NaCl. The sample was applied to a Superose 12 
HR 10/300 gel filtration column (GE Healthcare) equilibrated with buffer D. 
Pooled peak fractions were concentrated to 10 mg/ml. 
 
2.2.1.7 Purification of Pol III from S.cerevisiae 	  
The S.cerevisiae strain (Lannutti et al., 1996), carrying the gene for an N-
terminally His6-FLAG4-RET1-tagged C128 subunit on the parent plasmid 
pYE(CEN3)30 was grown to OD600 of 6-7 at 30°C in YPD media in a 200 l 
fermenter. Cells were harvested by continuous flow centrifugation at 20,000 
rpm in a Padberg centrifuge (Padberg Z4IG). 
Cells were lysed by bead beating in ice-cold buffer S500. The subsequent 
steps were performed at 4 °C. The lysate was cleared by centrifugation at 
8,000 g for 60 min in a SLA-1500 rotor (Sorvall). The supernatant was filtered 
and a whole cell extract was obtained after ultracentrifugation for 90 min at 
125,000 g in a Ti45 rotor (Beckman) and separation of the clear upper-middle 
phase from the turbid lower phase. The supernatant was further processed by 
stepwise ammonium sulfate precipitation. In the first step 35% (w/v) 
ammonium sulfate (0.125 g crushed (NH4)2SO4 per ml extract) were slowly 
added to the sample. After stirring for 30 min the sample was cleared by 
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centrifugation for 60 min at 8,000 g in a SLA-1500 rotor (Sorvall). The 
supernatant was precipitated by addition of 70% (w/v) ammonium sulfate 
(0.23 g/ml) and left stirring overnight. The pellet was recovered by 
centrifugation for 60 min at 8,000 g in rotor SLA-1500 (Sorvall) and diluted 
with 3 L of buffer D0-resuspension. The sample was loaded to a 250 ml 
Biorex 75 (Biorad) column equilibrated with buffer D200 and eluted with 500 
mM KCl (1:1 mixture of buffer D0-Äkta and buffer D1000). The eluted proteins 
were loaded on a manually packed 12 ml Ni-NTA (Qiagen) column, 
equilibrated with buffer D500+10i and subsequently washed buffer H250+10i. 
Bound proteins were eluted using buffer H250+250i. The resulting sample 
was further processed by an affinity chromatography step using a 5 ml HiTrap 
Heparin column (GE Healthcare). Bound protein was eluted applying a 
gradient from 250 mM to 1M (NH4)2SO4 using buffer H250 and H1000. Pol III 
elutes at ≈ 500 mM (NH4)2SO4. Pol III containing fractions were pooled and 
diluted 5-fold with MonoQ-0 buffer and subjected to anion-exchange 
chromatography using a MonoQ 10/100 GL column (GE Healthcare) and 
buffers MonoQ-0 and MonoQ-1000. Applying a salt gradient from 50 mM to 
1M (NH4)2SO4 resulted in elution of Pol III at a concentration of ≈600 mM 
ammonium sulfate. Pol III containing fractions were pooled and diluted to 50 
mM (NH4)2SO4. In order to overcome the slight endogenous substoichiometry 
of subunits C53/37 in the complex (Lorenzen et al., 2007) purified Pol III was 
supplemented with a 10-fold molar excess of the recombinantly expressed 
and purified C53/37 heterodimer and incubated for 60 min on ice. The sample 
was concentrated to a volume of approximately 1 ml and finally purified by 
size-exclusion chromatography using a Superose 6 10/300 GL column (GE 
Healthcare) and buffer Superose6KCl. The sample was either immediately 
used for experiments or flash-frozen in liquid N2 after the addition of 10% (v/v) 
glycerol. 
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2.2.2 Crystallization of Pol I and attempts on solving the structure 	  
2.2.2.1 Crystallization by vapor diffusion 	  
Pol I was purified as described and subsequently concentrated to 5.5 mg/ml 
(1.5, 3.0 and 4.0 mg/ml for Pol I ΔA49/A34.5) using Amicon ultra centrifugal 
devices with a molecular weight cutoff of 10 kDa (Millipore). Protein 
concentrations were determined measuring the UV absorption at 280 nm 
using a NanoDrop 1000 (Thermo Scientific) assuming an extinction coefficient 
of 422,925 M-1 cm-1 and 390,480 M-1 cm-1 (calculated with ProtParam on 
www.expasy.org) for Pol I and Pol I ΔA49/A34.5, respectively. For slow 
sample concentration the centrifuge speed was reduced to 5,000 – 6,000 rpm 
at 4°C. In order to remove dust and aggregated particles, the concentrated 
sample was centrifuged at 14,000 rpm for 30 min at 4°C before crystallization. 
Crystallization by vapor diffusion was carried out in hanging drops as well as 
in sitting drops. For hanging drops EasyXtal 24-well crystallization plates 
(Nextal/Qiagen) were used. Hanging drops were set using 500 µl reservoir 
solution and 1 µl protein + 1 µl reservoir drops. The protein drop was set prior 
to the addition of reservoir solution. Additionally the reservoir contained 3 mM 
Tris(2-carboxyethyl)phosphine (TCEP) as reducing agent. Initial crystallization 
screens were set up at the crystallization facility of the MPI for biochemistry 
using 96-well sitting drop plates and commercially available screening 
solutions.	  	  
2.2.2.2 Streak-seeding 	  
Crystals suitable for performing X-ray diffraction experiments could only be 
obtained using streak-seeding (Bergfors, 2003). Hanging drop crystallization 
setups were allowed to equilibrate for 3-3.5 h prior to streak-seeding. Seeds 
were derived from source drops by the addition of 10 µl of reservoir solution 
containing fresh reducing agent. In order to obtain suitable seeds crystals in 
the source drop were shred by pipetting. Cat whiskers were used to collect 
seeds from the source drop by streaking the whiskers through the diluted 
source drop. The collected seeds were then added to at least 6 identical 
  Materials and Methods	  
	   27	  
drops yielding a consecutive seed dilution. The wells were immediately closed 
after streak-seeding. 
 
2.2.2.3 Crystal harvesting and cryo-protection 	  
Crystals that had reached their maximum size of about 500 µm x 60 µm x 10 
µm were harvested using crystal manipulation and freezing tools (Hampton 
Research). Drops that contained suitable crystals were diluted by adding 5 µl 
reservoir solution. For cryo-protection crystals were transferred to to spot 
plates containing 100 µl reservoir solution supplemented with 6% (v/v) PEG 
400 and 3% freshly prepared TCEP. After 30 min equilibration time the 
concentration of the cryo-protectant was increased stepwise to 12%, 18% and 
22% (v/v) PEG-400 by exchanging the respective cryo-solutions. The final 
step was repeated for another 30 min to ensure complete exchange of the 
cryo-solution. 
 
2.2.2.4 Heavy atom derivatization and crystal freezing 	  
Prior to heavy atom derivatization of Pol I crystals the crystals were 
transferred to the final cryo-solution containing 22% PEG-400 and slowly 
cooled down to 8°C. Grains of different heavy atom clusters (see Table 17) 
were added to the crystals. The crystals were kept at 8°C for different time 
periods according to the heavy atom derivate that was added (see Table 17). 
Crystals were harvested using 20 µm CrystalCap HT equipment (loop size 
0.1-0.6 mm, sample holder length 22 mm) (Hampton Research). Harvested 
crystals were instantly plunged into liquid nitrogen and stored at -196°C until 
data collection. 
 
2.2.2.5 Crystallization of Pol I elongation complexes 	  
In order to obtain different crystals or crystal forms Pol I was crystallized in the 
presence of nucleic acids. Nucleic acids were either co-crystallized with Pol I 
or soaked into previously obtained Pol I crystals. 
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For co-crystallization purified Pol I was incubated with a 2x molar excess of 
pre-annealed minimal nucleic acid elongation constructs, EC1 and EC2, for 
20 min at 20°C shaking at 350 rpm in Superose 6 buffer A (EC1: non-
template DNA: 5’-CGCTCGACCTCG-3’, template DNA: 3’-
GATCTGGTCCTGTGCGAGCTGGAGC-5’, RNA: 5’-FAM-GACCAGGAC-3’; 
EC2: non-template DNA: 5’-CGCTCGACCTCG-3’, template DNA: 3’-
CTGGTCCTGTGCGAGCTGGAGC-5’, RNA: 5’-FAM-
AACGGAGACCAGGAC-3’). The mixture was then directly subjected to 
crystallization setups using commercially available screens using a Hydra II 
crystallization robot (BioRad). 
In order to soak nucleic acid scaffolds (EC1 and EC2) into pre-existing Pol I 
crystals the crystals were transferred into spot plates containing Pol I cryo-
solutions (see Chapter 2.2.2.3) supplemented with 10 µM nucleic acids. The 
cryo-solutions containing nucleic acids were exchanged every 30 min. The 
final step was repeated and allowed to incubate for 30 min or overnight before 
the crystals were flash-frozen in liquid nitrogen. 
 
2.2.2.6 Data collection 	  
All diffraction data was recorded at beamline X06SA at the Swiss Light 
Source (SLS) in Villigen, Switzerland using the Pilatus 6M detector (Dectris, 
Baden, Switzerland). In order to verify that soaked heavy metal clusters are 
present in the crystals, X-ray absorption scans were performed at specific 
absorption edges of the used heavy metal derivatives (e.g. L-III edge of 
tungstate at 10.21 keV) prior to the actual diffraction experiment. Because of 
extreme sensitivity of the crystal towards radiation damage the beam flux was 
kept constant at 1 x 1012 photons/s to enable for comparison of diffraction 
quality between different crystals. Furthermore the beam was focused on the 
detector rather than on the sample to reduce radiation damage. Simulated 
strategies (calculated with XPLAN, part of the XDS package, (Kabsch, 1993)) 
for the data collection were used to minimize X-ray exposure. However, 
despite all precautions, several translations on a single crystal were 
necessary to record a full dataset at roughly the same resolution. This in turn 
introduced severe problems concerning data integration and scaling. 
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2.2.2.7 Data processing 	  
Data were processed using the XDS software package (Kabsch, 1993). 
During integration most difficulties arose from changes in the unit cell 
parameters, which were induced by the severe radiation damage of Pol I 
crystals. This made refinement of these parameters difficult. The often 
observed high mosaicity of > 0.7° and many different translations impaired 
scaling with XSCALE (part of the XDS package). Images suitable for scaling 
were determined by monitoring the average I/σ and the batch-wise R-factor in 
the XSCALE output file. Data quality criteria of I/σ ≥ 2 and an Rmerge of < 40% 
were applied before phasing attempts. 
Self-rotation functions were calculated using GLRF (Tong and Rossmann, 
1990) and stereographic projections were calculated for κ = 51° and κ = 180°. 
Wilson-Plots were calculated using SFCHECK (Vaguine et al., 1999). 
 
2.2.2.8 Molecular replacement 	  
Various models based on the Pol II structure (Armache et al., 2003) as well as 
reconstructions derived from cryo-EM (Kuhn et al., 2007) were used for 
molecular replacement trials. All models were used for molecular replacement 
employing PHASER (McCoy et al., 2005; Read, 2001; Storoni et al., 2004). 
For using cryo-EM maps in molecular replacement attempts the maps had to 
be converted to the CCP4 format using SPIDER (Frank et al., 1996). The 
spider volume was interpolated to 1 Å/pixel and the resulting volume was 
embedded into a 300 Å x 300 Å x 300 Å unit cell. After determination of the 
center of gravity the molecule was shifted  to this center and the map was 
finally converted to CCP4 format using CP to CCP4 in 32 bit mode. Resulting 
maps were used as search models in molecular replacement together with the 
self-rotation information calculated previously. 
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2.2.3 In vitro RNA assays 	  
2.2.3.1 RNA extension assays using nucleic acid scaffolds 	  
Complete Pol I, Pol I ΔA49/A34.5 or Pol I A12.2ΔC were incubated for 30 min 
at 20°C with 2 pmol of a pre-annealed minimal nucleic acid scaffold (template 
DNA: 3’-GCTCAGCCTGGTCCGCATGTGTCAGTC-5’; non-template DNA: 5’-
C ACACAGTC AG-3’; RNA: 5’-FAM-UGCAUAAAGACCAGGC-3’). 
For complementing Pol I ΔA49/A34.5, a 5-fold molar excess of recombinant 
A49/A34.5 was incubated with Pol I ΔA49/A34.5 for 10 min at 20°C before 
assembly of the polymerase-nucleic acids complex. For elongation, 
complexes were incubated in the presence of 1 mM NTPs at 28°C for 20 min 
in transcription buffer (see Table 15). Reactions were stopped by addition of 
an equal volume of 2x loading buffer (Table 15) and incubation at 95°C for 5 
min. 6-FAM labeled RNA extension products were separated via gel 
electrophoresis using polyacrylamide gels containing 8 M urea and visualized 
with a Typhoon 9400 imaging system (GE Healthcare). 6-FAM was excited 
with blue light at a wavelength of 𝛌 = 488 nm and the fluorescent signal was 
recorded with a 520 BP 40 band-pass filter. 
For extension assays with a complementary bubble (Kireeva et al., 2000) 6 
pmol Pol I or Pol I ΔA49/A34.5 were incubated with 3 pmol of a scaffold 
containing template DNA and RNA (template DNA: 3’- 
TGCGCACCACGCTTACTGGTCCGTTCGCCTGT CCTCGACCA-5’; RNA: 5’- 
FAM-UGCAUUUCGACCAGGC-3’) for 15 min at 20°C. The complementary 
bubble was made complete by addition of a 5-fold molar excess of non-
template DNA (5’- TTTTTACGCGTGGTGCGAATGACCAGGCAAGCGGACA 
GGAGCTGGT-3’) to the polymerase-RNA-template DNA complex and 
incubation for 15 min at 25°C. The emerged polymerase-nucleic acids 
complexes were incubated in the presence of 1 mM NTPs at 28°C for 1 and 5 
min in transcription buffer. Reactions were stopped and analyzed by gel 
electrophoresis as described above. 
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2.2.3.2 RNA cleavage assays 	  
Complete Pol I, Pol I ΔA49/A34.5 and Pol I A12.2ΔC was incubated for 30 
min at 20°C with a nucleic acid scaffold that comprised an RNA with a 6-FAM 
fluorescent label at its 5’-end and a three-nucleotide mismatched overhang at 
its 3’-end (template DNA: 3’-TTACTGGTCCTTTTTCATGAACTCGA-5’; non-
template DNA: 5’-TAAGTACTTGAG CT-3’; RNA: 5’-FAM-UGCAUU 
UCGACCAGGACGU-3’, overhanging nucleotides underlined). For RNA 
cleavage reactions, samples were incubated in transcription buffer at 28°C for 
up to 30 min. The resulting RNA species were analyzed by gel 
electrophoresis and fluorescence detection as described. 
 
2.2.4 Crosslinking and mass spectrometry 	  
2.2.4.1 Chemical crosslinking of multi-subunit protein complexes 	  
Pol I, Pol I in complex with Rrn3 and Pol III were cross-linked using 
isotopically coded disuccimidyl suberate (DSS-d0/d12, Creative Moelcules 
Inc.). The optimal DSS to protein ratio was determined by mixing 8 µg aliquots 
of the respective protein complex with 25 mM DSS dissolved in 
dimethylformamide (DMF, Pierce Protein Research Products) (DSS 
concentration refers to the concentration of one isotope) to a final DSS 
concentration of 0.02 mM, 0.04 mM, 0.08 mM, 0.16 mM, 0.4 mM, 0.8 mM, 1 
mM, 2mM and 4 mM, respectively. As the best concentration the 
concentration was chosen, which was sufficient to convert most of the 
individual polymerase subunits into a higher molecular weight band avoiding 
oligomers of the respective complexes. 
Purified Pol I (100 µl containing 110 µg Pol I) was mixed with 25 mM DSS 
dissolved in DMF to a final concentration of 0.6 mM DSS and incubated for 30 
min at 30°C and 350 rpm. The reaction was stopped by the addition of 1 M 
NH4HCO3 to a final concentration of 100 mM and incubation for at least 15 
min at 30°C. Purified Pol I – Rrn3 complex was concentrated to 1 mg/ml (total 
amount 70 µg) and mixed with 25 mM DSS to a final concentration of 1.2 mM 
DSS. The mixture was incubated for 30 min at 30°C and 350 rpm. The cross-
linking reaction was stopped by addition of 1 M NH4HCO3 to a final 
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concentration of 100 mM, incubating for at least 15 min at 30°C and 350 rpm. 
Pol III (95 µl containing 100 µg Pol III) was crosslinked accordingly, using a 
final DSS concentration of 1 mM. 
To increase the crosslink yield, Pol I and Pol III were also crosslinked with 
DSS concentrations of 3.5 mM and 3 mM DSS, respectively. In order to 
separate potential polymerase oligomers, which might have emerged during 
crosslinking, a final size exclusion step was added to the crosslinking 
protocol. Therefore Pol I was subjected to a Superose 6 10/300 GL column 
using Superose 6 buffer C supplemented with 100 mM NH4HCO3. Size 
exclusion chromatography of Pol III after crosslinking was performed in 
Superose6KCL buffer containing 100 mM NH4HCO3. 
 
2.2.4.2 Sample preparation for MS analysis 	  
The cross-linked proteins were linearized by addition of two sample volumes 
of 8 M urea and subsequently reduced and alkylated using 5 mM Tris(2-
carboxyethyl)phosphine (TCEP) and 10 mM iodoacetamide, respectively. The 
sample was digested using trypsin following standard protocols. Purified 
samples were reconstituted in 20 µl of SEC mobile phase buffer. 15 µl of 
reconstituted sample were applied to a Superdex Peptide PC 3.2/20 column 
at a flow rate of 50 µl/min. For LC-MS/MS, fractions of interest (retention 
volume 0.9-1.4 ml) were pooled and evaporated to dryness. 
 
2.2.4.3 Mass spectrometry 	  
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis was 
carried out on an Eksigent 1D-NanoLC-Ultra system connected to a LTQ 
Orbitrap XL mass spectrometer (Thermo Scientific) equipped with a standard 
nanoelectrospray source. Fractions from size exclusion chromatography 
(SEC) were reconstituted in mobile phase buffer. The injection volume was 
chosen according to the 215 nm absorption signal from SEC separation. A 
fraction corresponding to an estimated amount of 1 µg was loaded onto a 11 
cm x 0.075mm I.D. column pre-packed with Michrom Magic C18 material (3 
µm particle size, 200 Å pore size) (Michrom Bioresources, Inc.). Peptides 
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were separated at a flow rate of 300 nl/min using a stepwise gradient from 
0.05% (v/v) to 92% (v/v) acetonitrile. 
Ion source and transmission settings of the mass spectrometer were set as 
follows: Spray voltage 2 kV, capillary temperature 200°C, capillary voltage 60 
V and tube lens voltage 135 V. The mass spectrometer was operated in data-
dependent mode, selecting up to five precursors from a MS1 scan (resolution 
60,000) in a m/z range from 350-1600 for collision induced dissociation (CID). 
Single and double charged precursor ions and precursors of unknown charge 
states were rejected. CID was performed for 30 ms using 35% normalized 
collision energy and an activation of q=0.25. Dynamic exclusion was activated 
with a repeat count of 1, exclusion duration 30 s, list size of 300 and a mass 
window of ±50 ppm. Ion target values were 1,000,000 (or maximum 500 ms 
fill time) for full scans and 10,000 (or maximum 200 ms fill time) for MS/MS 
scans, respectively. 
 
2.2.4.4 Database searching 	  
For data analysis, Thermo Xcalibur .raw files were converted to the open 
mzXML format with the help of ReAdW version 4.3.1 using default settings. 
The mzXML files were used as input for xQuest searches. For the following 
MzXML2Search (part of Trans-Proteomics Pipeline, (Keller et al., 2005)) the 
files were converted to the .mgf (Mascot generic file) format. MzXML2Search 
was executed with the option “-T10000” to export precursors with a mass 
above the default value of 4,2000 Da. 
Unmodified peptides from the protein mix were identified by searching an in-
house Mascot server (ver. 2.3.0) against the Uniprot/SwissProt data with 
following parameters: Maximum number of missed cleavages = 2, taxonomy = 
chordata, fixed modifications = carbamidomethyl-Cys, variable modification = 
Met oxidation, MS1 tolerance = 15 ppm, MS2 tolerance = 0.6 Da, instrument 
type = ESI-TRAP and decoy mode set to on. For validation, the peptide 
probability was set to p < 0.05 and additional filters were used (require bold 
red = yes, peptide score ≥20). 
Cross-linked peptides and peptide mono-links were identified using an in-
house version of the dedicated search engine xQuest applying a scoring 
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model as described (Walzthoeni et al., in preparation). Tandem mass spectra 
of precursors differing in their mass by 12.075321 Da (mass difference DSS-
d0 and DSS-d12) were paired if they had a charge state of 3+ to 8+ and were 
triggered within 2.5 min of each other. These spectra were then searched 
against a pre-processed .fasta database. For the protein mixture, the 
database contained the UniProt/SwissProt entries of the target proteins. 
xQuest search parameters were set as follows: Maximum number of 
missed cleavages (excluding the cross-linking site) = 2, peptide length = 4-40 
amino acids, fixed modifications = carbamidomethyl-Cys (mass-shift = 
57.02146 Da), mass-shift of the light cross-linker = 138.06808 Da, mass-shift 
of mono-links = 156.078644 and 155.096428 Da, MS1 tolerance = 15 ppm, 
MS2 tolerance = 0.2 Da for common ions and 0.3 Da for cross-link ions. The 
search was carried out in enumeration mode (exhaustive search). The search 
results were filtered (MS1 tolerance window = -4 to +7 Da) and all spectra 
were manually validated. Identifications were only considered for the result 
list, when both peptides had at least four bond cleavages in total or three 
adjacent ones and a minimum length of six amino acids. 
 
2.2.5 Figure preparation 	  
Figures were prepared with CHIMERA (Pettersen et al., 2004) and PYMOL 
(DeLano Scientific). 	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3 Results and Discussion 	  
3.1 Purification of Pol I variants 	  
3.1.1 Purification of Pol I ΔA49/A34.5 	  
In order to confirm the assignment of EM densities near the Pol I funnel (see 
Chapter 3.3.1), cryo-EM studies with a Pol I variant lacking those subunits 
had to be performed. As the purification of Pol I from a GPY2 strain lacking 
the gene for subunit A34.5, which leads to a loss of A34.5 as well as A49, 
failed at the cation exchange step, we decided to dissociate the Pol I specific 
subunits by treatment with urea (Huet et al., 1975). Therefore the Pol I 
preparation was performed as described (Kuhn et al., 2007). After cation 
exchange chromatography the sample was diluted 5-fold with 25% MonoQ 
buffer B and dialyzed against Mono Q buffer C overnight at 4°C. Dissociated 
A49 and A34.5 could be removed from the sample by anion exchange 
chromatography (Figure 7). 
 
 
Figure 7. Chemical dissociation of A49/A34.5. (A) Chromatogram from anion exchange 
chromatography. Absorption at 280 and 260 nm are depicted as blue and red curve, 
respectively. Green and brown curves represent the concentration steps and conductivity, 
respectively. (B) SDS-PAGE analysis. The main peak (H9-H4) contains Pol I ΔA49/A34.5 
while the Pol I-specific subunit stay in the flow-through (FT). 
 
Urea was removed from the same by size exclusion chromatography and the 
peak fractions were concentrated and immediately used for experiments 
(Figure 8). The chemical dissociation yielded approximately 30-50 µg of Pol I 
ΔA49/A34.5. 
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Figure 8. Comparison of Pol I and Pol I ΔA49/A34.5. (A) Size-exclusion chromatography of 
Pol I (blue) and Pol I ΔA49/A34.5 (lime). The peak of the Pol I variant lacking A49/A34.5 is 
shifted by approximately 1 ml. (B) SDS-PAGE analysis confirms the loss of the Pol I-specific 
subunits (right lane). 
 
3.1.2 Purification of Pol I A12.2ΔC 	  
Pol I lacking the C-terminal domain of subunit A12.2 was purified from a 
Δrpa12 strain carrying a plasmid coding for the A12.2 N-terminus and linker 
region (amino acids 1-78) (see Chapter 2.1.1, Table 4). The purification was 
carried out exactly as for complete Pol I, except that gelfiltration was ommited 
(Figure 9).  
 
 
Figure 9. Purification of Pol I A12.2ΔC. (A) Cation exchange chromatography profile. The 
peak containing Pol I A12.2ΔC is labeled. (B) SDS-PAGE (silver stain) after cation exchange 
chromatography. A band for the truncated A12.2 variant appears at ≈ 8kDa. 
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The purification only yielded ≈ 10 µg Pol I A12.2ΔC from 240 g of yeast cells, 
which were harvested from approximately 50 L of yeast culture. The very low 
yield of this variant only allowed for usage in in vitro transcription assays. 
Cryo-EM and crystallization setups could not be carried out due to the lack of 
reasonable amounts of Pol I A12.2ΔC. 
 
3.2 Crystallization of Pol I and attempts on structure solution 	  
3.2.1 Crystallization of complete Pol I 	  
Crystals of Pol I could be grown in reservoir solutions containing 100 mM 
HEPES pH 7.5, 3% (v/v) MPD, 9-11% PEG 6000 and 3 mM TCEP using 
freshly prepared Pol I at a concentration of 4-5.5 mg/ml. Crystals appeared 
after 3-4 days and grew to their maximum size within 7-10 days. However, 
those setups only yielded very small crystals with a maximum size of 50 -100 
µm in their largest dimension. In order to increase the crystal size, and thus 
their potential diffraction power, initial crystals were used as starting material 
for streak-seeding experiments (Bergfors, 2003). Pre-equilibrated drops 
(equilibration time 3-4 h) were seeded using cat-whiskers (see Chapter 
2.2.2.2) and a PEG 6000 concentration of 9% (w/v), whereas initial crystals 
mostly appeared at a PEG concentration of 10% (w/v). The seeding approach 
led to a substantial increase in crystal size up to dimensions of 500 µm x 70 
µm x 20 µm for some single crystals (Figure 10A). Despite the increase in 
crystal size in some cases, streak-seeding did not lead to a better 
reproducibility. The crystal size as well as crystal morphology was dependent 
on a large variety of factors such as initial cell material, purification and 
equilibration time, quality and freshness of the seeds, the cat-whisker that was 
used etc. Even slightest changes in the crystallization procedure led to the 
disappearance of suitable crystals. Typically, crystallization setups with one 
Pol I batch derived from 300 g of yeast cells yielded 80-100 hanging drops, of 
which approximately 10 contained crystals suitable for diffraction experiments. 
 In order to overcome possible sub-stoichiometric binding of the Pol I 
specific subunits A49/A34.5 to the core, which had been observed in native 
MS experiments (Geiger et al., 2010), Pol I was pre-incubated with a 5-molar 
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excess of recombinantly expressed A49/A34.5 (see Chapter 2.2.1.6) for 1h on 
ice. After subsequent removal of unbound A49/A34.5 by gelfiltration 
crystallization experiments were set up. Ironically, this complementation led to 
a complete loss of Pol I crystals in initial setups as well as in drops that were 
subjected to streak-seeding. 
 
 
Figure 10. Pol I crystals. (A) Improved Pol I crystals after streak-seeding. (B) Pol I crystals 
obtained from screening setups at the MPI of Biochemistry. Crystals were grown in 20% PEG 
3350 and 50 mM Tris pH 8.0. 
 
Additionally, after the establishment of a state-of-the-art crystallization facility 
at the MPI of Biochemistry (Martinsried), Pol I was subjected to another round 
of initial screening using commercially available crystallization screens. Pol I 
crystallized in a condition containing 20% PEG 3350 and 50 mM Tris pH 8.0 
(Figure 10B). However, the obtained crystals could not be reproduced in 24-
well crystallization plates despite numerous optimization trials screening for 
different precipitant concentrations, protein concentrations, protein to 
precipitant ratios etc. 
 
3.2.2 Crystallization of Pol I elongation complexes 	  
Cryo-EM reconstructions (see Chapter 3.3.1) revealed a highly mobile clamp 
domain in Pol I, which could possibly interfere with successful crystallization 
and structure solution by X-ray diffraction. Therefore crystallization trials with 
Pol I were also carried out in the presence of nucleic acid scaffolds. To 
increase the rigidity of Pol I, minimal nucleic acid scaffolds were either soaked 
into existing Pol I crystals or co-crystallized with Pol I. For these trials two 
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different minimal scaffolds were used, one with a 9 bp DNA/RNA hybrid and a 
second one also with a 9 bp hybrid and a 6 bp overhang at the 5’ end of the 
RNA (see Chapter 2.2.2.5).  
For soaking experiments Pol I crystals were transferred from their source 
drops to a spot plate containing the original mother liquor supplemented with 
10 µM nucleic acids (see Chapter 2.2.2.5). After back-soaking using mother 
liquor without nucleic acids, the soaking efficiency was checked by 
fluorescence microscopy showing that the 6-FAM labeled scaffolds were 
present in the crystals (Figure 11). However, Pol I crystals soaked with 
minimal nucleic acids scaffolds never showed ordered diffraction. 
 
 
Figure 11. Fluorescence microscopy of soaked Pol I crystals. (A) Bright field image of a 
Pol I crystal soaked with 6-FAM labeled nucleic acids. (B) The same crystal viewed using an 
excitation filter at λ=500 nm (optimal excitation of 6-FAM at λ=494 nm), confirming that 
labeled nucleic acids are present in the crystal. (Crystal cracked due to use of a cover slide.) 
 
As a second approach, Pol I was co-crystallized with the same nucleic acid 
scaffolds that were used for soaking experiments. Therefore Pol I was pre-
incubated with a two-fold molar excess of nucleic acids (see Chapter 2.2.2.5) 
and subsequently used in initial screening setups. Co-crystallization 
experiments yielded initial crystals in different conditions containing either 
CaCl2 or rather high concentrations of potassium acetate (Figure 12). 
Diffraction experiments using the PX Scanner at the MPI of Biochemistry 
revealed that all crystals grown in CaCl2 containing conditions were salt-
crystals. Crystals grown in potassium acetate containing conditions did not 
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exhibit any visible diffraction upon X-ray exposure, suggesting they might be 
bona fide Pol I crystals. However, the initial crystal could not be reproduced in 
24-well hanging drop plates despite broad range screening. 
 
 
Figure 12. Initial crystals of Pol I co-crystallized with nucleic acids. The upper panel 
shows initial crystals and the lower panel their respective diffraction pattern (PX Scanner, MPI 
of Biochemistry). (A) Crystals grown in condition with high concentration of KOAc shows no 
diffraction on a weak X-ray source, leaving the possibility of being protein crystals. (B)(C) 
Crystals grown in conditions containing CaCl2 show strong spots in diffraction experiments 
indicating salt crystals. 
 
3.2.3 Crystallization of Pol I ΔA49/A34.5 	  
In order to crystallize Pol I in a different crystal form, a few crystallization trials 
were set up using the Pol I variant lacking the specific subunits A49/A34.5. 
Drops were set up using a hand-made crystallization screen composed of 
known crystallization conditions for Pol II (4-7% (w/v) PEG 6000, 50 mM 
HEPES pH 7.0, 200 mM NH4OAc, 300 mM NaOAc) and Pol I (8-12% PEG 
6000 (see Chapter 3.2.1)). Some pseudo-crystals could be observed in the 
known Pol I crystallization condition (Figure 13) but they could not be 
optimized and transformed into crystals of reasonable quality for X-ray 
diffraction experiments. Initial large-scale screening could not be performed in 
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this case because the approach of chemically dissociating A49/A34.5 from 
Pol I only yielded 30-50 µg protein per purification. 
 
  
 
 
Figure 13. Pseudo-crystals of Pol I 
ΔA49/A34.5. Formation of pseudo-crystals 
occured in crystallization conditions for 14-
subunit Pol I at concentration of PEG 6000 of 
9.5%. 
 
 
3.2.4 Crystal manipulation and heavy atom derivatization 	  
The diffraction quality of Pol I crystals remained one of the major issues 
throughout the trials of solving the Pol I structure by X-ray crystallography. 
Native Pol I crystals often showed only poorly ordered diffraction as well as a 
high degree of mosaicity and often anisotropic diffraction (Figure 14A). Crystal 
handling approaches such as crystal dehydration using increased PEG 
concentrations or cryo-annealing (Harp et al., 1999) did not improve the 
diffraction quality of Pol I crystals but in most cases led to a complete loss of 
diffraction (Table 17). Heavy atom derivatization, which had been exploited in 
order to gain experimental phase information, turned out to introduce order in 
the crystal lattice. 
Various heavy atom compounds have been tested for their ability to improve 
diffraction quality of Pol I crystals (Table 17). The most positive effect on 
diffraction quality was observed when crystals were soaked with a W18-cluster 
for 40-44h at 8°C (Figure 14B). All heavy atom compounds were added as 
grains to the final cryo-solution. The improved diffraction of crystals soaked 
with heavy atom compounds could be due to tighter crystal packing induced 
by these additives. In case of crystals soaked with W18 the size of the unit cell 
was decreased by 1.5-2% in each dimension. 
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Table 17. Post-crystallization manipulation of Pol I crystals. 
Manipulation 
method 
Component Protocol Result 
W18-cluster soak (NH4)6(P2W18O62) ⋅ 14 
H2O 
 
Soaking for 40-44 h 
at 8°C 
Best diffraction up to 
4-4.5 Å 
W18 back-soak (NH4)6(P2W18O62) ⋅ 14 
H2O 
Soaking for 40-44 
h, backsoaking for 
10-15 min in final 
cryo-solution 
 
Same as normal W18-
soak, same radiation 
damage 
Ir3-soak (NH4)4Ir3N(SO4)6 24/48 h at 8°C 
 
No diffraction 
Cs-Os soak Cs3Os2NCl8 ⋅  
2 H2O 
24/48 h at 8°C Diffraction to 8-9 Å 
Cs-W soak Cs6W5P2O23 24/48 h at 8°C Non-ordered 
diffraction up to 7 Å 
Pt soak K2PtCl4 24/48 h at 8°C 
 
No diffraction 
Mersalyl acid 
soak 
C13H18HgNO6 1 week at 8°C 
 
No diffraction 
W30-Cluster soak (NH4)14[NaP5W30O10] 24/48 h at 8°C No diffration 
Tantalum-
Bromide soak 
Ta6Br122+ 1-3 h @ 20°C or 
overnight at 8°C 
 
Very poor diffraction 
Tungsten-
Bromide soak 
W6Br122+ 1-2 h or overnight 
at 8°C 
 
No ordered diffraction 
beyond 6-7 Å 
Mercury soak 2,4,6-Trisaeceto-(3-
aminoaceto)-
mercuritoluol 
 
30 min – 3 h @ 
20°C 
No diffraction 
Cryo-annealing --- Crystal thawed and 
re-frozen in cryo 
stream 
 
No diffraction 
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Manipulation 
method 
Component Protocol Result 
Dehydration 25% PEG 6000 Crystal soaked in 
final cryo solution 
containing 25% 
PEG 6000 for 15 
min at 20°C before 
freezing in liquid N2 
 
No diffraction 
Crystal pre-
cooling 
 
 Pre-cool for 24h at 
4°C before freezing 
Slightly better 
diffraction than native 
crystals (5.5 – 6 Å) 
 
Crystal freezing 
in cryo stream 
  Very weak diffraction 
 
 
	  
Figure 14. Diffraction patterns of native and soaked Pol I crystals. (A) Native Pol I crystal 
(SJ83) shows poorly ordered diffraction and anisotropy. (B) Pol I crystal soaked 44 h with 
W18-cluster (SJ4) shows nicely ordered diffraction up to 4 Å. 
 
3.2.5 Data collection and processing 
 
All datasets were collected at the SLS (Swiss Light Source) on beamline 
X06SA. If the crystals were soaked with heavy atoms, X-ray absorption scans 
were performed for every heavy atom species to test whether the compound 
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was present in the crystals. Due to severe radiation damage the crystals had 
to be translated several times in order to record complete datasets at 
reasonable resolutions. Since it was shown that datasets with a high 
completeness at very low resolution can facilitate structure determination by 
molecular replacement (Jenni and Ban, 2009) datasets for Pol I crystals were 
also recorded at low resolution (low resolution limit 300-400 Å) (Figure 15). 
Data were processed using XDS (Kabsch, 1993) and resulted in reasonable 
statistics to a resolution of 3.9 Å in the best case (Figure 14B). The resulting 
unit cell was monoclinic with a C2 symmetry and unit cell dimensions of a = 
617 Å, b = 306 Å, c = 251 Å and β = 97.3°. Anomalous signal (SigAno >1.2) of 
the soaked W18-cluster could only be observed in the lowest resolution shells 
indicating that the heavy atom clusters were not bound to the protein but 
rather diffusing in the solvent channels of the crystal. This, in turn, impaired 
experimental phasing and only left the possibility of molecular replacement 
approaches in order to determine the Pol I structure (see Chapter 3.2.7). 
 
 
Figure 15. Low resolution measurements and data statistics. (A) Diffraction pattern of low 
resolution measurements (crytsal SJ110) shows spots down to >300 Å resolution. (B) 
Processing with XDS results in a complete dataset from 310 – 7 Å. 
 
3.2.6 The Pol I asymmetric unit comprises seven Pol I molecules 
 
Calculating the Matthews coefficient (Matthews, 1968) with data observed for 
Pol I crystals suggested 7-9 copies of Pol I within the asymmetric unit and a 
solvent content of 45-55% (Figure 16A). When calculating the locked self-
rotation function (Tong and Rossmann, 1990) a very strong peak is observed 
at κ = 51° (Figure 16B) and 7 equally strong peaks are visible in the 
stereographic projection at κ = 180° (Figure 16C). This strongly argues for an 
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asymmetric unit comprising seven Pol I molecules related by a 7-fold non-
crystallographic symmetry axis (NCS) and 14 2-fold axes perpendicular to the 
7-fold axis. The 7-fold axis is oriented along c while the 2-fold axes, one each 
25.7°, lie near the ab plane. Taken together these results demonstrate that in 
the present crystal form the asymmetric unit likely contains 7 Pol I molecules 
with a total mass of almost 4.2 MDa. 
 
 
Figure 16. Organization of the Pol I asymmetric unit. (A) Calculation of the Matthews 
coefficient suggests 7-9 Pol I molecules in the asymmetric unit. (B) Stereographic projection 
of the self-rotation function at κ = 51° shows a 7-fold NCS axis along c. (C) Stereographic 
projection of the self-rotation function at κ = 180° shows 7 2-fold NCS axes in one polar 
coordinate hemisphere resulting in a total number of 14 2-fold NCS axes near the ab plane. 
The peaks at the poles are symmetry-equivalent. 
 
3.2.7 Attempts on structure determination by molecular replacement 	  
Initial molecular replacement attempts were carried out using Pol II-based 
based search models, using either the complete 12-subunit Pol II structure 
(Armache et al., 2005) or Pol II bound to TFIIS (Kettenberger et al., 2003). 
Additionally, molecular replacement trials using the Pol I EM density (see 
Chapter 3.3.1) were carried out employing different programs such as 
MOLREP (Vagin and Teplyakov, 1997), amore (Navaza, 1994), Phaser 
(Mccoy et al., 2007) and Replace (Tong, 1993). However, molecular 
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replacement attempts with crystallographic search models never resulted in 
groups of seven rotational solutions representing the predicted 7-fold axis in 
the asymmetric unit. In order to use EM maps as search model for molecular 
replacement, P1 unit cells containing one copy of the EM volume were 
generated. The structure factors for this model were calculated and used for 
molecular replacement. Calculation of the rotation function with this model 
resulted in 7 solutions related by a 7-fold axis. However, the translation 
function for the obtained rotation solutions could not be solved. 
In subsequent molecular replacement trials, search models were introduced 
that already contained copies of 7 seven Pol I molecules in order to restrain 
the translational search (Figure 17A). These ring-shaped models were 
constructed by counterclockwise rotation of the Pol I EM volume based on 
peaks observed by applying the locked rotation function (Figure 17B).  
 
 
Figure 17. Heptamer ring models for molecular replacement. (A) Potential 7-mer ring 
based on Pol I cryo-EM reconstructions (Chapter 3.3.1). (B) Counterclockwise rotation of the 
Pol I EM density preserves the internal 7-fold NCS (1) while clockwise rotation does not (2). 
Schemes 3-8 show all possible start points of the 7-mer rings derived from counterclockwise 
rotation based on locked rotation function peaks. 
 
Approximately 22,000 ring models varying in diameter and molecule positions 
were employed in extensive grid searches in order to obtain a solution of the 
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translation function and, thus, to gain initial phase information. Despite these 
exhaustive efforts, no translational solution could be obtained using available 
diffraction data of Pol I. An even more extensive approach of allowing internal 
movement (e.g. rotation) of single Pol I molecules within the heptameric 
search model was not pursued because the number of searchable models 
would grow exponentially so that this approach was limited by the available 
computing power. However, if it would be possible to solve this large 
asymmetric unit one could largely benefit from phase improvement by 7-fold 
NCS-averaging. 
 
3.3 Cryo-electron microscopic studies on Pol I 	  
3.3.1 Cryo-EM structure of Pol I at 12 Å resolution 	  
For cryo-EM studies, Pol I was purified as described (see Chapter 2.2.1.1) 
and kept on ice until further usage. The optimal protein concentration for cryo-
EM was determined by electron microscopy using negative stain (Figure 18A). 
Particles did not form aggregates and showed high particle density. Even 
under cryo-conditions (≈ 100 K) particles could be easily identified and 
apparently behaved nicely during vitrification (Figure 18B). Cryo-EM 
reconstruction of Pol I with 46,056 particles led to a map at 11.9 Å resolution 
(Figure 18C) as judged by the Fourier shell correlation (FSC) function plot, 
applying a cutoff value of FSC = 0.5. 
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Figure 18. EM reconstruction of Pol I. (A) Negatively stained Pol I. (B) Pol I variant 
ΔA49/A34.5 under cryo conditions. (C) Cryo-EM reconstruction of Pol I. Views and structural 
regions are named according to the Pol II structure (Cramer et al., 2001). 
 
Interpretation of the EM map was achieved by first placing the crystal 
structure of the Pol II 10-subunit core into the EM map as a rigid body by 
fitting the common five subunits, which were known to occupy similar 
positions on the polymerases’ surface (Jasiak et al., 2006). A perfect fit of the 
common subunits confirmed the high quality of the map (Figure 19). Many 
regions of the homologous subunits fitted equally well, but strong deviations 
were also observed. 
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Figure 19. Placement of the 10-subunit Pol II core into EM density. (A) Placement of the 
Pol II core structrue (Armache et al., 2005) (grey) into the EM density (blue). Subunits Rpb5, 
Rpb8 and Rpb9 are highlighted in magenta, green and organge respectively. (B) Fit of the 
common subunits Rpb5 and Rpb8 into the EM map. 
 
3.3.2 Cryo-EM structure of Pol I ΔA49/A34.5 	  
After assigning EM-densities to the Pol I core, an additional large density 
remained on the enzyme surface that was assigned to the Pol I-specific 
subunits A49 and A34.5 (Figure 19A). To confirm this assignment, subunits 
A49 and A34.5 were dissociated from Pol I using urea (Huet et al., 1975) (see 
Chapter 2.2.1.2) and the resulting 12-subunit Pol I was purified and its 
structure was solved by cryo-EM at 25 Å resolution (Figure 20). The structure 
was similar to the complete Pol I, except that the density assigned to A49 and 
A34.5 was lacking. In addition, there was a minor change in the clamp 
conformation, which probably represents an average clamp position, and is 
unlikely to result from the absence of A49/A34.5. Density assigned to A49 and 
A34.5 is located near the enzyme funnel, the external domain 1, a conserved 
core loop with a Pol I-specific insertion (corresponding to loop α16-β20 of the 
Pol II pore domain), and A12.2. This is consistent with the loss of A49 when 
Pol I is purified from A12.2 deletion strains (Van Mullem et al., 2002). 
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Figure 20. Overlay of EM structures of 
Pol I ΔA49/A34.5 (silver surface) and 
the complete Pol I (blue). The density 
assigned to A49/A34.5 is highlighted 
green. 
 
 
3.4 Functional studies on Pol I 	  
3.4.1 A49/A34.5 acts as a build in elongation factor 	  
Bioinformatic analysis using HHPred (Soding et al., 2005) revealed 
homologies between A49/A34.5 and N-terminal regions of the two large 
subunits of human TFIIF and thus suggested that A49/34.5 has elongation 
stimulatory activity. Therefore, complete Pol I and Pol I ΔA49/A34.5 were 
compared in an RNA extension assay using a minimal DNA-RNA scaffold 
(see Chapter 2.2.3.1). The complete Pol I extended the RNA to the end of the 
template, whereas Pol I ΔA49/34.5 did not produce the run-off product (Figure 
21A). Addition of recombinant A49/34.5 rescued the defect of Pol I ΔA49/34.5, 
and enabled elongation to the end of the template (Figure 21A, lane 4). The 
elongation experiments were repeated using a complete, complementary 
transcription bubble scaffold (Fig. 21B) (Kireeva et al., 2000). The complete 
Pol I produced the run-off transcript (+18), whereas Pol I ΔA49/34.5 did not, 
but addition of recombinant A49/34.5 heterodimer restored run-off formation 
(Fig. 21B, lanes 6+7). The defect was not due to differential binding of the 
polymerase variants to the scaffold, as it was also observed when the 
elongation complexes were covalently coupled to magnetic beads and 
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extensively washed before the reaction (not shown). Reduced elongation 
activity in the fully complementary system arises from a more sophisticated 
complex assembly, resulting in a higher proportion of RNA not bound to Pol I. 
Taken together, A49/34.5 is required for normal elongation activity of Pol I in 
vitro. 
 
 
Figure 21. Elongation stimulatory activity of A49/A34.5. (A) A49/34.5 shows elongation- 
stimulatory activity in RNA extension assays with a minimal nucleic acid scaffold. The 
fluorescent label 6-carboxy-fluoresceine (FAM) on the RNA 5’-end is indicated. The times 
molar excess of added factors are indicated above the lanes. For lane 4, Pol I ΔA49/34.5 was 
complemented with a fivefold molar excess of recombinant A49/34.5 for 10 min at 20 °C prior 
to addition of the scaffold. (B) Elongation assay as in (A) but with a complete complementary 
bubble (Kireeva et al., 2000). 
 
3.4.2 Pol I has intrinsic cleavage activity that requires A12.2 	  
The active site of Pol II exhibits weak 3’-RNA cleavage activity that is 
stimulated by TFIIS (Wind and Reines, 2000). For Pol I, an RNAse H-like 
nuclease activity was initially described (Huet et al., 1976), but was later found 
to reside in a dissociable factor (Huet et al., 1977; Tschochner, 1996). To 
clarify whether Pol I possesses intrinsic RNA cleavage activity, a 
“backtracked” elongation complex was assembled using purified Pol I and a 
DNA-RNA scaffold that contained an RNA 3’-overhang (Figure 22 and 
Chapter 2.2.3.2). Incubation of the backtracked complex with 8 mM 
magnesium ions led to efficient shortening of the RNA from the 3’-end (Figure 
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22B, lanes 1-3). In more detail, Pol I mainly removed four nucleotides from the 
RNA, consistent with binding of the terminal hybrid base pair to the nucleotide 
insertion site (+1), extrusion of the RNA 3’-overhang into the polymerase 
pore, and cleavage of the phosphodiester bond between nucleotides at 
positions –1 and +1. In comparison, Pol II was unable to cleave the RNA 
under these conditions, but addition of TFIIS resulted in cleavage (Figure 22B, 
lanes 8-11). The Pol II-TFIIS complex removed three or four nucleotides, 
indicating that a mixture of complexes was present with the terminal hybrid 
base pair occupying either position -1 or +1. Taken together, Pol I has a 
strong intrinsic RNA cleavage activity not present in Pol II. 	  
	  
Figure 22. Intrinsic RNA cleavage activity of Pol I. (A) DNA-RNA hybrid scaffold used in 
cleavage assays. (B) Comparison of RNA cleavage by Pol I variants with Pol II and the Pol II- 
TFIIS complex. (C) pH-Dependence of Pol I cleavage activity. 
 
The intrinsic cleavage activity likely escaped detection previously since the 
nucleic acid substrates used in published studies did not allow for the 
formation of a backtracked state, from which cleavage occurs. The previously 
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described dissociable factor (Huet et al., 1977; Tschochner, 1996) may not be 
required for cleavage per se, but may induce backtracking of Pol I, to create a 
state of the elongation complex that is prone to cleavage. 
Additional cleavage assays showed that the Pol I variant ΔA49/34.5 cleaved 
RNA less efficiently than the complete Pol I (Fig. 22B, lanes 4+5). Cleavage 
stimulation by A49/34.5 is consistent with an early investigation of an RNAse 
H-like activity in Pol I-containing fractions (Huet et al., 1976) (Huet et al., 
1976). The question arose, whether subunit A12.2 is required for cleavage, 
since its counterpart C11 is essential for cleavage activity of Pol III (Chedin et 
al., 1998). A Pol I variant lacking residues 79-125 of A12.2 (A12.2ΔC, Chapter 
3.1.2) was totally inactive in RNA cleavage (Fig. 22B, lanes 6+7), but bound 
the nucleic acid scaffold in electrophoretic mobility shift assays, and retained 
elongation activity (not shown). Consistent with a function specific for the 
A12.2 C-terminal domain, a truncation variant remains bound to Pol I and 
does not show a conditional growth defect (Van Mullem et al., 2002). 
The A12.2 C-terminal domain shows homology to the TFIIS C-terminal 
domain that inserts into the Pol II pore to stimulate RNA cleavage 
(Kettenberger et al., 2003). Mutation of the residues in A12.2 homologous to 
the catalytical D290 and E291 in TFIIS leads to a lethal phenotype, 
demonstrating their importance (not shown, data by Jochen Gerber, 
Regensburg). The conserved polymerase active site is capable of RNA 
cleavage in the absence of cleavage stimulatory factors, since free Pol II and 
the bacterial RNA polymerase can cleave RNA under mild alkaline conditions 
(Orlova et al., 1995; Weilbaecher et al., 2003). Consistently, the intrinsic 
cleavage activity of Pol I increased with increasing pH (Figure 22C). 
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3.5 Crosslinking reveals Pol I domain architecture and positions 
the Pol I-specific initiation factor Rrn3 	  
3.5.1 Crosslinking-MS analysis of Pol I 	  
To address unresolved questions on the functional architecture of Pol I, 
crosslinking-MS analysis were carried out for Pol I from the yeast 
Saccharomyces cerevisiae. Endogenous Pol I was purified as described 
(Gerber et al., 2008; Kuhn et al., 2007), except that the final size-exclusion 
chromatography step was carried out in the presence of potassium acetate 
(see Chapter 2.2.1.1). For crosslinking, 110 µg of Pol I were incubated with 
isotope-labeled disuccinimidyl suberate (DSS, Creative Molecules Inc.). DSS 
reacts with primary amines in lysine side chains and protein N-termini. 
Crosslinking was monitored by SDS-PAGE (Fig. 23A), and polymerase 
oligomers were removed by gelfiltration (see Chapter 2.2.4.1). After digestion 
with trypsin, crosslinked peptides were enriched by size exclusion 
chromatography, and peptides and their fragments were detected with high-
resolution MS (see Chapter 2.2.4.2 - 2.2.4.4). Measurement of the four 
samples, of which two were Pol I-Rrn3 complexes, resulted in 1047 mass 
spectra that matched crosslinked peptides, an example of which is shown in 
Figure 23B. 	  
3.5.2 Confirmation of the Pol I core model 	  
239 unique linkage pairs were identified within nine subunits of the Pol I core 
(subunits A190, A135, AC40, AC19, Rpb5, Rpb6, Rpb8, Rpb10, Rpb12; 
excluding A12.2, A49/34.5, and A14/43) (Figure 24A). The crosslinked 
residues were analyzed with the atomic Pol II structure (Armache et al., 2005) 
and the Pol I core homology model (Kuhn et al., 2007). We assumed that the 
distance between Cα atoms of crosslinked lysines must be ≤30 Å, 
corresponding to the length of the DSS spacer (11.4 Å) plus two times the 
length of a lysine side chain (6.5 Å) plus an estimated coordinate error of 3 Å 
for flexible lysine side chain ends. Crosslinking sites that fell in regions that 
adopt the Pol II fold (Kuhn et al., 2007) were assigned to category A (Table 
18). Sites outside these regions were assigned to category B.  
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Figure 23. Crosslining-MS analysis of Pol I. (A) SDS-PAGE analysis of Pol I crosslinked 
with different concentrations of DSS. (B) Fragmentation spectrum of a crosslinked peptide. 
The linkage site A190 K1624-A190 K457 was observed in the crosslinked peptide 
MSYETTCQFLTK(xl)AVLDNEREQLDSPSAR/TSGKVPIPGVK(xl)QALEK (m/z 1016.5261, 
5+; ‘xl’ denotes the crosslinked lysine). Extensive ion series for both peptides are observed in 
the fragmentation spectrum providing high confidence in the match. Peaks of the α- and β-
peptide are colored blue and ocher, respectively. Common ions are labeled in green and 
crosslink ions are labeled in red. (C) Cα distance distribution for experimentally observed A-A 
linkage pairs within the Pol I 9-subunit core (subunits A190, A135, AC40, AC19, Rpb5, Rpb6, 
Rpb8, Rpb10, and Rpb12). The generally allowed distance between the Cα atoms of two 
crosslinked lysine residues of 30 Å is indicated by a dashed line. Observed crosslinks are in 
agreement with the homology model for the Pol I core as judged by analysis with the Pol II X-
ray structure (PDB 1Y1V). 
 
Of the 239 crosslink pairs, 73 (30.5%) comprised only category A sites (A-A 
pairs), 80 (33.5%) contained one category B site (A-B pairs), and 86 (36%) 
were B-B pairs. Of the 73 A-A pairs, 70 could be analyzed (Kettenberger et 
al., 2004), because both crosslinked residues were present in the structure. 
Among the 70 A-A cross-link pairs, 68 (97.1%) fell within the acceptable Cα 
distance of ≤30 Å (Figure 23C). The two remaining pairs exceeded the 
maximum distance by only 1.9 Å and 4.3 Å, respectively, and this can be 
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explained by structural flexibility. One crosslink involves the bridge helix, 
which undergoes conformational changes (Brueckner et al., 2009; Cramer et 
al., 2001; Gnatt et al., 2001), whereas the other involves the clamp, which is 
mobile in Pol I (Kuhn et al., 2007) and Pol II (Cramer et al., 2001; Gnatt et al., 
2001; Kostrewa et al., 2009). We additionally obtained crosslinks within the 
A14/43 subcomplex, and between A14/43 and the Pol I core, which were 
consistent with the previously obtained structure and location of A14/43 
(Geiger et al., 2008; Kuhn et al., 2007). These results demonstrate the validity 
of our method, and confirm the previous Pol I model. 
 
Table 18. Crosslinking statistics and classification 
Crosslink 
pair type 
Observed 
pairs 
Both sites present 
in PDB 1Y1V 
Distance 
≤30 Å 
Comment 
A-A 73 70 68 (97.1%) 2 outliers involve mobile 
regions (bridge helix, clamp) 
A-B 80 65 39 (60.0%) 22 outliers comprise altered 
jaw residues1 
B-B 86 30 13 (43.3%) 13 outliers comprise altered 
jaw residues1 
B*-B2 232 172 2 (11.8%) 11 outliers comprise altered 
jaw residues1 
Total 239 165 120 (72.7%)  
1 The jaw region comprises A190 residues 1252-1487 
2 Crosslinks are a subgroup of B-B pairs ans therefore do not contribute to total number 
 
3.5.3 Model extension reveals a unique jaw 	  
To extend the Pol I model, category A-B and B-B crosslink pairs were 
analyzed (Table 18, Figure 24A). A-B pairs connect residues in regions of the 
homology model that share the Pol II fold (category A) with residues in 
sequence regions with no or very weak conservation (category B). Within the 
nine core subunits, we observed 80 A-B crosslinks, of which 15 could not be 
analyzed as they contain residues within specific insertions or residues that 
are not present in the Pol II structure. A total of 39 A-B pairs (60%) showed 
Cα distances below 30 Å. These residues were reclassified as B*, and their 
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surrounding region (overall 125 residues within A190, A135 and AC40) was 
included in the Pol I homology model, as it was likely that the region 
containing the B* site adopts a Pol II-like fold. Of the resulting 23 B*-B 
crosslinks, 17 pairs contained lysine residues present in the Pol II structure 
and two showed a permissible Cα distance. Based on these findings  the Pol I 
core model was extended to parts of the clamp core, pore, funnel, foot, dock, 
and cleft domains of the largest subunit A190, to small parts of the lobe, fork, 
and wall domains of the second largest subunit A135, and to parts of domain 
2, the loop domain, and the dimerization domain in subunit AC40, the 
counterpart of the Pol II subunit Rpb3 (Figure 24A, compare VI.1). The 
extended homology model relates 69.6% of the nine core Pol I subunit 
sequences to their Pol II counterparts, although the large Pol I subunits A190 
and A135 show only 25.5% and 25.6% sequence identity to their Pol II 
counterparts, respectively. 
Of the 166 A-B and B-B crosslinks within the Pol I core, 95 could be analyzed 
with the Pol II structure, of which 43 (26 A-B and 17 B-B crosslinks) did not fall 
within the Cα distance restraint of 30 Å (Table 18). Of these cross-links, 35 
involve residues that fall in a region that may correspond to the Pol II jaw 
domain (A190 residues 1252-1487). This region is conserved among yeast 
species, but is poorly conserved in higher eukaryotes. Secondary structure 
prediction (Jones, 1999) indicates that this region is only partially related to 
the Pol II jaw. Residues 1251-1337 are predicted to form three helices and 
two β-strands, residues 1338-1438 are apparently unstructured, and residues 
1439-1495 may form two helices and two β-strands. Crosslinks to residues 
K1260, K1269, K1473 and K1495 can be explained if residues in the two 
structured regions (1251-1337 and 1439-1495) adopt a structure and location 
similar to the Pol II jaw. In the unstructured region, residues K1363 and K1376 
form 32 crosslinks to regions in the polymerase cleft, including the bridge helix 
(Figure 24B). These crosslinks indicate that Pol I has a unique jaw domain 
with N- and C-terminal regions similar to the jaw domain in Pol II and an 
additional, mobile middle part that extends along the active center cleft. 
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Figure 24. Crosslink map and extended homology model for the Pol I core. (A) Crosslink 
map of the Pol I core. The primary structure of nine core subunits are shown schematically as 
boxes. Regions that show a conserved fold in Pol II are in green, insertions with respect to 
Pol II are colored in gray, and poorly or non-conserved parts are white. Extensions of the 
homology model derived from crosslink data are indicated in cyan and yellow for A-B and B*-
B crosslinks, respectively (compare VI.1). Black dashed lines and gray dashed arcs indicate 
inter-subunit and intra-subunit crosslinks, respectively. 
(B) Crosslinks of residues K1363 and K1376 of A190. Lysine residues in the polymerase core 
crosslinked to K1363 are in red (category A crosslink sites) or salmon (category B* sites) and 
the respective Cα atoms are shown as spheres. Cα atoms of lysine residues crosslinked to 
K1376 are shown as orange or light orange spheres, indicating category A and category B* 
linkage sites, respectively. The Pol II jaw domain is shown as a molecular surface. 
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3.5.4 A12.2 C-ribbon binds pore like TFIIS 	  
The crosslinking data provide the desired topological insights into the 
enigmatic A12.2 subunit, which is essential for the strong intrinsic cleavage 
activity of Pol I (see Chapter 3.4.2). A total of 27 cross-links was identified that 
contained sites in A12.2 (Figure 25A). Of those, 8 were intra-subunit cross-
links and 19 were cross-links between A12.2 and other Pol I subunits, which 
were analyzed with the coordinates of Rpb9 and TFIIS from the Pol II–TFIIS 
complex structure (PDB 1Y1V) (Kettenberger et al., 2004). The intra-subunit 
cross-links can be explained with the Rpb9 structure, and those in the C-
ribbon also with the TFIIS structure. Crosslinks between residue K46 of A12.2 
and two A190 residues (K1459, K1473) in the Pol I jaw (Figure 25A) and 
residue K298 in the lobe of A135 are consistent with a position of the A12.2 
N-ribbon similar to that of the Rpb9 N-ribbon on Pol II. Four crosslinks to K64, 
K68 and K73) fall within the linker between the N- and C-ribbon, which likely 
follows the path taken by the linker of TFIIS. The remaining 12 inter-subunit 
crosslinks unambiguously position the A12.2 C-ribbon in the Pol I pore. If one 
assumes that the A12.2 C-ribbon binds in the pore like the TFIIS C-ribbon, 11 
out of the 12 cross-links fall within the maximum distance restraint, and one 
cross-link exceeds the limit by only 2 Å (Figure 25B). In contrast, if one 
assumes that the A12.2 C-ribbon binds Pol I like the Rpb9 C-ribbon binds Pol 
II, only one out of 12 cross-links falls within the allowed Cα distance (Figure 
25C). These results show that the A12.2 N-ribbon binds the Pol I surface 
similar to the N-ribbon of Rpb9, whereas the A12.2 C-ribbon binds the Pol I 
pore, like the TFIIS C-ribbon binds Pol II. 
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Figure 25. The A12.2 C-ribbon binds the pore. (A) Schematic representation of the 
observed crosslinks involving A12.2. The ribbon domains of A12.2 are in orange. The color 
code is as in Figure 3A. (B) The A12.2 C-ribbon crosslinks to the Pol I core. Crosslinks were 
analyzed with the Pol II-TFIIS structure ((Kettenberger et al., 2004), PDB 1Y1V). The TFIIS 
C-ribbon is in orange, and its linker is shown as a dashed line. The Cα atoms of crosslinked 
residues are shown in orange and red for residues in A12.2 and A190, respectively. (C) 
Alternative analysis of the crosslinks between A12.2 and the Pol I core shown in B assuming 
that A12.2 adopt the location of Rpb9. Cα atoms of crosslinked residues are depicted as 
orange and red spheres for lysines belonging to A12.2 and the Pol I core, respectively. 
Crosslinks obeying the Cα distance restraint are shown as green lines; crosslinks exceeding 
the restraint as red lines. 
 
The A12.2 C-ribbon contains the charged residues R102, D105, and E106 at 
its tip, which correspond to TFIIS residues R287, D290, and E291, which 
complement the Pol II active site and induce strong RNA cleavage (Cheung 
and Cramer, 2011). These results are consistent with recent mutagenesis 
data that indicated that the corresponding Pol III subunit C11 also enters the 
pore with its C-ribbon to induce strong RNA cleavage (Ruan et al., 2011). The 
results thus explain the role of A12.2 and C11 in transcript cleavage (Chedin 
et al., 1998; Prescott et al., 2004), suggest a close evolutionary relationship 
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between Pol I and Pol III, and support the hypothesis that Pol I and Pol III 
differ from Pol II in their mode of RNA cleavage (Ruan et al., 2011). 
3.5.5 A49/A34.5 binds the lobe like TFIIF 	  
The data also position the dimerization module of the A49/34.5 subcomplex 
(Geiger et al., 2010) on Pol I. A total of 92 crosslinks involving the Pol I 
subcomplex A49/34.5 could be obtainede (Figure 26A). Within the 
dimerization module, 13 out of the 14 crosslinks agreed with the A49/34.5 
dimerization module structure (PDB 3NFF) (Geiger et al., 2010) (Figure 26B). 
The distance for one crosslink pair was slightly above the limit, but this was 
likely due to a difference in structures, since the structure was obtained from a 
different species, Candida glabrata. Crosslinks between the dimerization 
module and the Pol I core indicate that the module is positioned on one side 
of the Pol I cleft on the lobe domain of A135. A crosslink between A49 residue 
K116, which is seven residues beyond the A49 C-terminal residue in the 
dimerization module structure (PDB 3NFF), connects to the lobe of A135. 
Lysines located six and 12 residues beyond the A34.5 C-terminal residue in 
the structure crosslink to the external domains of A135, which are adjacent to 
the lobe. All these cross-links can be explained when we assumed that the 
A49/34.5 dimerization module occupies the location of the TFIIF dimerization 
module on the lobe of Pol II (Chen et al., 2010), but a 30º rotation of the 
module structure led to an even better fit (Figure 27A). 
These findings are consistent with the localization of the corresponding TFIIF 
dimerization module on the lobe of Pol II (Chen et al., 2010). Thus not only 
the structures of the dimerization modules of A49/34.5 and TFIIF are similar, 
but also their locations on the cores of Pol I and Pol II, respectively. Likewise, 
the C37/53 dimerization module binds the Pol III lobe, as shown by cryo-EM 
(Fernandez-Tornero et al., 2010; Vannini et al., 2010) and photo-crosslinking 
(Wu et al., 2011). The conserved location of the dimerization modules in all 
three polymerases is consistent with a similar function of the TFIIF-like 
subcomplex in transcription (Chen et al., 2010; Kassavetis et al., 2010). The 
observed stimulatory effect of the dimerization module on RNA cleavage 
(Geiger et al., 2010; Kuhn et al., 2007) can now be explained as an indirect 
effect resulting from its proximity to subunit A12.2, which is essential for 
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cleavage (see Chapter 3.4.2). This model is supported by the observation that 
deletion of C37 from Pol III leads to a loss of C11 (Landrieux et al., 2006). 
 
Figure 26. Crosslinks confirm A49/A34.5 domain structures. (A) Schematic overview of 
crosslinks involving the A49/A34.5 subcomplex. A49 and A34.5 domains of known structure 
are labeled. The color code is as in Figures 24A and 25A. (B) Crosslinks (green and red 
lines) are consistent with the known A49/A34.5 dimerization module structure (PDB 3NFG). 
Cα atoms of crosslinked residues are depicted as slate and pink spheres for A49 and A34.5, 
respectively. (C) Crosslinks are consistent with the structure of the A49 tWH domain (PDB 
3NFI). Cα atoms of crosslinked residues are represented as spheres. 
 
3.5.6 A49 tWH domain lies above the cleft 	  
We obtained seven crosslinks within the tandem winged helix (tWH) domain 
of A49 that were consistent with the structure of the isolated domain (Geiger 
et al., 2010) (Figure 26C). We further observed five crosslinks between the 
tWH domain and the Pol I core, namely to the lobe and protrusion of A135 on 
one side of the cleft, and to the Pol I-specific insertion in the clamp head 
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domain of A190 on the other side (Figure 27B). Extended alignments (see 
VI.1) based on HHPred predictions (Soding et al., 2005) position the 
crosslinked residues K259 and K267 of A190 6 and 14 residues beyond 
strand β4 in a Pol I-specific 52 amino acid insertion in the β4-β5 loop of the 
clamp head (Cramer et al., 2001). Additionally, the A49 residue K170, which 
is 15 residues N-terminal of the first ordered tWH residue, cross-links to the 
dimerization domain of A34.5, indicating proximity between the dimerization 
module and the tWH domain. The location of the tWH domain over the cleft is 
consistent with a role of this domain in DNA binding (Geiger et al., 2010), 
although a repositioning of this domain is required during promoter DNA 
loading into the cleft. It also corresponds to the location of the Pol III subunit 
C34 (Vannini et al., 2010), which may be evolutionary related to the A49 tWH 
domain (Geiger et al., 2010), and is similar to the position of TFIIE on the Pol 
II clamp (Chen et al., 2007). 
The A49 linker connecting the dimerization module with the tWH domain 
extends along the cleft, since it cross-links to a Pol I-specific insertion in the 
clamp head domain (residues K111/K309 and K250/K267 in the clamp head 
and the Pol I-specific insertion, respectively), and with residue K1012 in the 
bridge helix near the polymerase active center (Figure 27C). This location of 
the A49 linker is consistent with the location of the corresponding region in the 
largest TFIIF subunit on Pol II (Chen et al., 2007; Chen et al., 2010). The 
broad distribution of crosslinks involving the A49 linker over the central cleft 
and a crosslink to Rpb5 indicate that this region is mobile, consistent with 
NMR and circular dichroism measurements, which show that the linker is 
unfolded in solution (S. Geiger and P. Cramer, unpublished data). One 
crosslink connects the A49 linker to residue K5 in the mobile N-terminal tail of 
subunit A43, consistent with a genetic interaction between A49 and the N-
terminus of A43 (Beckouet et al., 2011). If extended, K5 in the mobile tail 
could be up to 60 Å away from the first ordered residue in the A43 structure 
(PDB 2RF4) (Geiger et al., 2008; Kuhn et al., 2007). Only a small number of 
crosslinks is observed to the C-terminal extension of A34.5, including 
crosslinks to subunits AC40 and AC19 (Figure 27C). 
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Figure 27. Location of the A49/34.5 subcomplex on the Pol I core. (A) The A49/34.5 
dimerization module resides on the polymerase lobe. The A49/34.5 dimerization module 
structure has been placed on the Pol I surface manually based on the indicated crosslinks to 
the Pol I subunit A135. Crosslinks used for domain positioning are depicted as green dashed 
lines. Crosslink sites on the Pol I surface are highlighted in color and the crosslinked residues 
are labeled. (B) The A49 tWH domain can reside over the cleft. The A49 tWH domain has 
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been placed over the central cleft of Pol I using two crosslink pairs involving subunit A135 and 
two crosslinks to a Pol I-specific insertion in the clamp head domain of A190. The cross-link 
sites on Pol I are colored in blue and the Cα atoms of the involved lysines in the A49 tWH 
domain are shown as spheres and labeled with the crosslinked residue number. Crosslinks 
used for domain positioning are depicted as green dashed lines. The apparent mobility of the 
domain is indicated by an arrow. (C) Additional crosslinks indicate that the A49/34.5 
subcomplex spans a large surface area. Crosslinks to A34.5 are colored in light pink and 
deep pink for the dimerization module and the A34.5 C-terminus, respectively. Crosslinks to 
the A49 tWH domain are depicted in blue and crosslinks to the A49 linker are shown in dark 
violet. Only crosslink positions of the A49 linker and the A34.5 C-terminus are labeled with 
their respective residue numbers. For crosslink sites that are not part of the structures, the 
nearest residue is colored and labeled with an asterisk. 
 
Overall, the data indicate that the mobile A49 linker extends into the central 
cleft of Pol I and that the C-terminal tWH domain can be located above the 
cleft. This position is similar to that of C34 in the Pol III system, as revealed by 
cryo-EM (Fernandez-Tornero et al., 2010; Vannini et al., 2010). Bioinformatic 
analysis (Carter and Drouin, 2010) and homology modeling (Geiger et al., 
2010) suggested an evolutionary relationship of C34 and the A49 tWH domain 
to the β subunit of TFIIE. Since TFIIE crosslinks to the clamp of Pol II (Chen 
et al., 2007), the A49 tWH domain, C34, and TFIIE can all adopt similar 
locations on their respective polymerase cores. Consistent with this, recent 
results showed that the A49 tWH domain binds single-stranded DNA and 
suggested a role in promoter binding and/or opening (Geiger et al., 2010). 
Since the Pol III subunit C82 also binds single-stranded DNA (Lefevre et al., 
2011) and the archaeal TFIIE homologue TFE stabilizes an open promoter 
complex (Grunberg et al., 2007; Micorescu et al., 2008), we suggest that the 
distantly related A49 tWH domain, the Pol III subcomplex C82/34/31, and 
TFIIE share an old function in binding the melted DNA region above the active 
center cleft in an open promoter complex during initiation. Loading of the DNA 
into the cleft may be enabled by the observed mobility of these proteins. 
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3.5.7 Rrn3 binds Pol I near subcomplex AC40/19 	  
To elucidate the molecular basis for binding of the Pol I-specific initiation 
factor Rrn3, of which the structure was solved by X-ray crystallography 
(Blattner et al., 2011), the Pol I–Rrn3 complex was subjected to chemical 
crosslinking and mass spectrometry. A pure Pol I–Rrn3 complex was 
crosslinked with 1.2 mM DSS, and subsequently analyzed by MS (see 
Chapter 2.2.4). The analysis revealed two high-confidence crosslinks between 
Rrn3 and Pol I, connecting Rrn3 residue K558 to Pol I residues K582 and 
K329 in subunits A190 and AC40, respectively (Figure 28). The crosslinked 
Pol I residues are located on the ‘‘back’’ of the homologous Pol II structure 
near the Rpb3/11 heterodimer, which corresponds to the AC40/19 
heterodimer. To obtain a model for the Pol I–Rrn3 complex, the Rrn3 structure 
was positioned on the polymerase such that the crosslinks were explained. 
The crosslinked Rrn3 residue K558 is part of the short mobile loop α20–α21 
that follows the ordered residue G554, which was allowed to be up to 30.9 Å 
from crosslinked Pol I lysines (the theoretical maximum Cα distance of 27.4 Å 
plus 3.5 Å for mobile residues 555–558).  Only one Rrn3 orientation 
positioned the serine patch towards Pol I, to explain the interaction data 
(Blattner et al., 2011) without producing protein clashes (Figure 28). In the 
resulting model of the Pol I–Rrn3 complex, Rrn3 extends from the RNA exit 
tunnel and dock domain alongside A14/43, the counterpart of the Pol II 
subcomplex Rpb4/7, to AC40/19. The model explains Rrn3 binding to the OB 
domain of subunit A43 (Peyroche et al., 2000), an early electron microscopic 
projection (Peyroche et al., 2000), the observation that Rrn3 can be fused to 
A43 in vivo (Laferte et al., 2006), and an apparently stabilizing effect of A14 
on the Rrn3–Pol I interaction (Imazawa et al., 2005) 
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Figure 28. Model of the Pol I-Rrn3 complex based on crosslinking and MS. Back view of 
a 12-subunit Pol I model that is based on the Pol II core structure (silver) (Armache et al., 
2005) and the structure of subcomplex A14/43 (red/blue) (Kuhn et al., 2007). The Pol II core 
heterodimer Rpb3/11 that is homologous to the Pol I heterodimer AC40/19 is highlighted in 
red/yellow. The positioned Rrn3 structure (Blattner et al., 2011) (green) contains a lysine 
residue (K558) that is part of a short mobile loop following the ordered residue G554 (cyan 
dot) and cross-links to two Pol I residues (cyan dots connected with dashed lines). 
Crosslinked positions in the Pol I core are revealed in the homologous Pol II structure; K582 
in A190 corresponds to M437 in Rpb1, and K329 in AC40 corresponds to L259 in Rpb3 (cyan 
dots). Positions C92 and A159 in Rpb3, influencing the interaction of Pol II with the Mediator 
head module (Soutourina et al., 2011), are indicated as gray spheres. 
 
3.5.8 Comparison of crosslinking and EM-Data 	  
Comparison of the crosslinking data presented here with previously obtained 
EM data on Pol I strongly suggests that the A49/34.5 subcomplex, like its 
counterpart TFIIF, maintains a considerable degree of mobility on the 
polymerase surface. In a cryo-EM reconstruction at 12 Å resolution (see 
Chapter 3.3.1), densities were observed spanning from the funnel of Pol I to 
the AC19/40 heterodimer, consistent with some crosslinks described here for 
the A49 linker and the A34.5 tail, respectively (Figure 27C), but did not show 
densities on the lobe (Kuhn et al., 2007). An early EM investigation at lower 
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resolution provided evidence for A49 and A34.5 over the cleft (Bischler et al., 
2002), although at that time a clear assignment was not possible. These 
observations can be reconciled with the mobility of A49/34.5. The two 
structured domains of this subcomplex are mobile but have preferred 
locations on the Pol I surface in solution, which are detected by crosslinking 
and by EM at low resolution, but not by EM at high resolution, where mobile 
surface structures often get blurred or disappear. Taken together, the present 
data derived from crosslinking an MS analysis provides the complete 
structural architecture of Pol I at the level of protein domains, explains the 
function of surface domains, and further elucidates the evolutionary 
relationships between the three eukaryotic RNA polymerases. 
 
3.6 Crosslinking analysis of Pol III 	  
3.6.1 Crosslinking confirms the Pol III homology model 	  
Crosslinking-MS experiments were also carried out for 17-subunit Pol III in 
order to gain additional insights into its domain architecture. Therefore, 
complete Pol III from S.cerevisiae was purified (see Chapter 2.2.1.7) and 
subjected to chemical crosslinking and mass spectrometry analysis as 
described for Pol I (see Chapter 2.2.4.1-2.2.4.4 and 3.5.1) (Figure 29A). 
Measurements of two samples, crosslinked with 1.2 mM and 3.5 mM DSS, 
resulted in 654 mass spectra that matched crosslinked peptides. 
Within the nine subunits of the Pol III core 158 unique linkage pairs were 
observed (subunits C160, C128, AC40, AC19, Rpb5, Rpb6, Rpb8, Rpb10, 
Rpb12; excluding C11, C17/C25, C53/37, and C82/34/31) (Figure 30). The 
crosslinked residues were analyzed with the atomic Pol II structure 
(Kettenberger et al., 2004) and the Pol III core homology model (Jasiak et al., 
2006). 
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Figure 29. Crosslinking-MS analysis of Pol III. (A) SDS-PAGE of Pol III crosslinked with 
different concentrations of SDS. (B) Cα distance distribution for experimentally observed A-A 
linkage pairs within the 9 subunit Pol III core (subunits C160, C128, AC40, AC19, Rpb5, 
Rpb6, Rpb8, Rpb10, and Rpb12). The generally allowed distance between Cα atoms of two 
crosslinked lysine residues of 30 Å is indicated by a dashed line. Observed crosslinks are in 
agreement with the homology model for the Pol III core as judged by analysis with the Pol II 
X-ray structure (PDB 1Y1V). 
 
The maximum allowed distance between Cα atoms of crosslinked lysins was 
set to ≤30 Å, similar to crosslink analysis with Pol I (see Chapter 3.5.2). 
Crosslinking sites that fell in regions that adopt the Pol II fold (Jasiak et al., 
2006) were assigned to category A, sites outside this regions to category B 
(Table 19). Of the 158 crosslink pairs, 66 (41.8%) comprised only category A 
sites (A-A pairs), 57 (36.1%) contained one category B site (A-B pairs), and 
35 (22.1%) were B-B pairs. Of the 66 A-A pairs, 61 could be analyzed, 
because both crosslinked residues were present in the structure 
(Kettenberger et al., 2004). Among the 61 A-A crosslink pairs, 58 (95.1%) fell 
within the acceptable Cα distance of ≤30 Å (Figure 29B). The three remaining 
pairs exceeded the maximum distance by 0.3 Å, 3 Å and 28.8 Å, respectively. 
The violation of the distance restraint, in case of the first two crosslink pairs 
(Cα distance 30.3 Å and 33.0 Å), can be explained by structural flexibility. 
Both crosslinks comprise residue K371 of the largest subunit C160, which is 
situated within the clamp domain. This domain has been shown to be mobile 
in Pol II (Cramer et al., 2001; Gnatt et al., 2001; Kostrewa et al., 2009) as well 
as in Pol I (Kuhn et al., 2007). Additionally, crosslinks within the C17/C25 
subcomplex were obtained as well as between C17/C25 and the Pol III core 
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(C160 and Rpb6), which were consistent with the previously obtained 
structure and location of C17/C25 (Jasiak et al., 2006). Only one of 61 
crosslinks appears to be false, which results in a false discovery rate of 1.5%. 
These results demonstrate the validity of the method and confirm the previous 
Pol III model. 
 
Table 19. Crosslinking statistics and classification 
Crosslink 
pair type 
Observed 
pairs 
Both sites present 
in PDB 1Y1V 
Distance 
≤30 Å 
Comment 
A-A 66 61 58 (95.1%) 2 outliers involve mobile 
clamp domain 
A-B 57 38 35 (92.1%) 1 outliers involves mobile 
clamp domain 
B-B 35 14 13 (92.9%)  
 
B*-B1 131 51 51 (100%)  
 
Total 158 113 106 (93.8%)  
1 Crosslinks are a subgroup of B-B pairs and therefore do not contribute to total number 
 
3.6.2 Extension of the Pol III homology model 	  
To extend the Pol III model, category A-B and B-B crosslink pairs were 
analyzed (Table 19, Figure 30). A-B pairs connect residues in regions of the 
homology model that share Pol II fold (category A) with residues in sequence 
regions with no or very weak conservation (category B). Within the nine core 
subunits 57 A-B crosslinks were observed, of which 19 could not be analyzed 
as they contain residues within specific insertions or residues that are not 
present in the Pol II structure. In total, 35 A-B pairs (92.1%) showed Cα 
distances below 30 Å. These residues were reclassified as B*, and their 
surrounding region (overall 150 residues within C160, C128 and AC40) was 
included in the Pol III homology model, as it was likely that the region 
containing the B* site adopts a Pol II-like fold. Of the resulting 13 B*-B 
crosslinks, five contained lysine residues present in the Pol II structure and all 
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of them showed a permissible Cα distance. Based on these findings, the Pol 
III homology model could be extended to parts of the clamp core, clamp head, 
pore, and jaw domains of the largest subunit C160, to parts of the external 1, 
protrusion and fork domains as well as to small parts of the lobe of subunit 
C128 and to parts of the zinc loop, domain 2, and loop domain of AC40, the 
counterpart of the Pol II subunit Rpb3 (Figure 30, compare VI.2). The 
extended homology model relates 85.8% of the nine-subunit Pol III core 
sequences to their Pol II counterparts, although the large Pol III subunits 
C160 and C128 show only 33.2% and 35.7% sequence identity to their Pol II 
counterparts, respectively. 
 
 
Figure 30. Crosslink map and extended homology model for the Pol III core. The 
primary structure of nine core subunits are shown schematically as boxes. Regions that show 
a conserved fold are in green, insertions with respect to Pol II are colored in gray, and poorly 
or non-conserved parts are white. Extensions of the homology model derived from crosslink 
data are indicated in cyan and yellow for A-B and B*-B crosslinks, respectively (compare 
VI.2). Black dashed lines and gray dashed arcs indicate inter-subunit and intra-subunit 
crosslinks, respectively. 
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3.6.3 C53/C37 binds the lobe like TFIIF and connects to C11 	  
Bioinformatic analysis and homology modeling suggested that the Pol III-
specific subunits C53/37 form a dimerization module similar to that of 
A49/34.5 and TFIIF in Pol I and Pol II, respectively (Geiger et al., 2010). 
Crosslink analysis of 17-subunit Pol III also enabled for positioning of the 
C53/37 dimerization module on the Pol III core. In total, a number of 129 
crosslinks involving the C53/37 subcomplex could be obtained (Figure 31A). 
 
 
Figure 31. Crosslinks confirm the homology model for C53/37. (A) Schematic overview of 
crosslinks involving the C53/37 subcomplex. The proposed dimerization module formed by 
C53 and C37 is labeled in pink and slate blue, respectively. Insertions with respect to the 
A49/A34.5 dimerization module are depicted in gray. Known domains of Pol III-specific 
subunits C82 and C34 are colored and labeled. (B) Crosslinks are consistent with the 
homology model of the C53/C37 dimerization module (Geiger et al., 2010). Cα atoms of 
crosslinked residues are depicted as pink and slate spheres for C53 and C37, respectively. 
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Within the dimerization domains 22 intra- and inter-peptide crosslinks were 
obtained of which seven could be analyzed, as both crosslinked residues 
were present in the model (Figure 31B). Of those, six crosslinks fell within the 
maximum Cα distance of ≤30 Å and one exceeded the limit by only 3.1 Å, 
which is considered acceptable as the present model is derived from 
homology modeling. Crosslinks between the dimerization module and the Pol 
III core indicate that the C53/C37 dimerization module is positioned on one 
side of the Pol III cleft on the lobe domain of C128. Crosslinks of residue K194 
of C37, which is ten residues beyond the last residue present in the model, 
connect to the lobe of C128 and the jaw of C160. A crosslink between C53 
residue K274, which is 9 residues N-terminal of the first residue in the 
homology model, connects to the funnel of C160, which is adjacent to the lobe 
(Figure 32A). All crosslinks can be explained when one assumes that the 
C53/37 dimerization module occupies the location of the TFIIF dimerization 
module, but a slight shift towards the jaw domain lead to an even better fit. 
The location of the C34 derived from crosslinking and MS experiments is also 
strongly supported by cryo-EM reconstructions of Pol III (Fernandez-Tornero 
et al., 2010; Vannini et al., 2010) (Figure 32B) and findings from photo-
crosslinking experiments (Wu et al., 2011), that place the dimerization domain 
at a similar position on the Pol III surface. 
Furthermore, a variety of crosslinks to the Pol III core involving the N-terminal 
part of C53 and the C37 C-terminus could be observed (Figure 32C). The N-
terminus of C53 crosslinks to the external domain of C128, to Rpb6, as well 
as to the dock, funnel, cleft and jaw domain of C160. Also crosslinks to the 
Rpb4/7 homolog C17/C25 as well as the coiled coil domain of the specfic 
subunit C82 were observed consistent with results from photo-crosslinking 
experiments (Wu et al., 2011). The broad distribution of crosslinks to the 
highly charged C53 N-terminus indicates a certain mobility of this part of the 
protein similar to the observed mobility for the charged C-terminus of A34.5, 
the C53 homolog in Pol I (see Chapter 3.5.6). The C-terminal part of C37 
crosslinks to the protrusion of C128 as well as to the winged helix domains of 
C34, the potential homolog of TFIIE and the A49 tWH domain. These 
crosslinks are consistent with photo-crosslinking data (Wu et al., 2011) and 
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resemble in part the location of the A49 linker in Pol I (see Chapter 3.5.6), 
which connects the A49 dimerization domain with the A49 tWH domain. 
 
 
Figure 32. Location of the C53/37 subcomplex on the Pol III core. (A) The C53/37 
dimerization module resides on the polymerase lobe. The model of the dimerization module 
has been placed on the polymerase surface manually based on the indicated crosslinks to 
C160 and C128. Crosslinks used for domain positioning are depicted as green dashed lines. 
Crosslink sites on the Pol III surface are highlighted with the respective color and the 
crosslinked residues are labeled. (B) Overlay of the model derived from crosslinking-MS 
analysis and a cryo-EM reconstruction at 10 Å (pale cyan) (Fernandez-Tornero et al., 2010). 
(C) Additional crosslinks to the C53 N-terminus and the C37 C-terminus show that the 
C53/C37 subcomplex spans a large surface area on Pol III. Crosslinks to C53 and C37 are 
depicted in pink and slate, respectively. Only crosslink positions to the C53 N-terminus and 
the C37 C-terminus are labeled with their respective residue numbers. For crosslink sites that 
are absent from the depicted structures, the nearest residue is colored and labeled with an 
asterisk. 
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Also crosslinks between the C53 N-terminus and the C11 linker could be 
observed (Figure 31A), suggesting an interaction of C53/37 with C11. This is 
supported by the observation that deletion of C37 leads to a loss of C53 as 
well as C11 (Landrieux et al., 2006). Also two crosslinks between the C11 C-
ribbon and the jaw and cleft domain of C160 were observed. However, 
inspection with help of the structure of Pol II bound to TFIIS (PDB 1Y1V) 
(Kettenberger et al., 2004) did not reveal a preferred location of the C11 C-
ribbon as it was the case for A12.2 on Pol I (see Chapter 3.5.4) since the 
observed crosslinks did not satisfy the Cα distance restraint neither assuming 
an Rpb9-like nor a TFIIS-like binding of the C-ribbon. This suggests that the 
C11 C-ribbon exhibits a higher degree of mobility than its Pol I counterpart 
A12.2. This mobility is consistent with X-ray studies on an Rpb9-C11 fusion 
protein, which was active in RNA cleavage assays, but density was only 
visible for the Rpb9 N-ribbon (Ruan et al., 2011).  
 
3.6.4 Location of the C82/34/31 subcomplex 	  
Crosslinking yielded 82 intra- and inter-subunit crosslinks involving the Pol III-
specific subunits C82/34/31 (Figure 33A). All crosslinks were analyzed using 
the Pol III homology model (Jasiak et al., 2006) and homology models for C82 
and C34. For C31 the intra-subunit crosslinks could not be analyzed due to a 
lack of structural information and no evident homologies to known structures, 
as judged by HHPred analysis (Soding et al., 2005). 
Crosslink analysis of C82 yielded 16 intra-subunit crosslinks, of which 6 could 
be analyzed with a homology model derived from the structure of the human 
homolog C62 (Lefevre et al., 2011) using Modeller (Eswar et al., 2006). All six 
crosslinks fell within the Cα distance restraint of ≤30 Å and thus agreed with 
the calculated model (Figure 33B). The remaining crosslinks contained at 
least one crosslinked residue located in loops or insertions specific for 
S.cerevisiae and thus could not be analyzed. 
In case of C34, two different models were calculated based on NMR 
structures of winged helix domains from C34 homologs in M.musculus and 
H.sapiens (PDB 2DK8, 2DK5, and 2YU3, He et al., unpublished). Modeling 
with PDB 2DK8 and 2DK5 resulted in a model, in which the winged helix 
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domains were connected by an extended linker (Figure 33C) whereas 
modeling with 2DK5 and 2YU3 (domain swapped winged helix of Rpc39) 
resulted in a more condensed model (Figure 33D). Inspection of both models 
showed that in the model comprising the extended linker only 5 out of 8 
crosslinks satisfied the distance restraint whereas in the condensed model all 
eight crosslinks fell within the maximum Cα distance of ≤30 Å (Figure 33C,D). 
Thus, crosslink analysis supports a compact arrangement of the C34 winged 
helix domains, similar to the arrangement of the WH domains in the A49 tWH 
domain. 
 
 
Figure 33. Crosslinks of the C82/34/31 subcomplex. (A) Schematic overview of crosslinks 
involving C82/34/31. The extended winged helix domains (eWH) of C82 are labeled and 
colored, insertions with respect to C62 are depicted as grey boxes. Winged helix domains of 
C34 are labeled and coloured in purple. C53/37 domains are colored and labeld as in Fig. 30. 
(B) Crosslinks (green lines) are consistent with the model of C82, which is based on the X-ray 
structure of Rpc62 (Lefevre et al., 2011). The extended winged helices are colored and 
labeled according to (A). (C) Crosslinks (green and red lines) deny the possibility of an 
extended linker between the WH domains of C34 (modeled with PDB 2DK8 and 2DK5). (D) 
Crosslinks are consistent with a C34 model that shows a dense packing of the WH domains. 
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Inspection of the inter-subunit crosslinks revealed distinct locations of the 
three specific subunits, C82/34/31, on the Pol I core (Figure 34A). C31 
crosslinks to Rpb5 as well as to the clamp head and linker domains of C160. 
For subunit C34 crosslinks between WH2 and the protrusion of C128 could be 
observed. Crosslinks to C82 can be observed in the clamp head and funnel 
domains of C160 and in subunits Rpb5 and Rpb6. Also two crosslinks of C82 
to the Rpb3 homolog AC40 were obtained but it is likely that these are false 
positive results since AC40 is located opposite to all other C82 crosslink sites 
on the polymerase core. 
 
 
Figure 34. Crosslinks of the Pol III specific subcomplex C82/34/31. (A) Crosslinked 
residues on the Pol III surface. Crosslinks to C82, C34, and C31 are colored yellow, purple 
and magenta, respectively. One crosslink position is shared by C82 and C81 and is labeled 
and colored wheat. The possible locations of the C82, C34, and C31 are indicated by ellipses. 
Overlapping ellipses indicate that C34 and C31 crosslink to C82 in different regions. (B) Inter-
subunit crosslinks of C82. Cα atoms of residues that crosslink to C34 and C31 are depicted 
as purple and magenta spheres, respectively. Cα atoms of lysines crosslinked to the Pol III 
core are labeled and depicted as grey spheres. 
 
Despite several available crosslink sites on the Pol III surface, an 
unambiguous placement of the C82/C34/31 subcomplex was not possible for 
several reasons. First, the unavailability of structural information for C31 
hampered the placement dramatically, since most of the crosslinks to the Pol 
III core involved C31 residues. Second, out of seven crosslinks to the Pol III 
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core, three involved C82 residues that are located in a large yeast-specific 
insertion in extended winged helix 2 (eWH2) (Figure 33A). Third, residues 
K520 and K594 of C82 both crosslink to Rpb5 K171 (Figure 34B) but are ≈55 
Å apart from each other in the C82 model (and the C62 structure PDB 2XUB), 
which leaves only a few possibilities to place C82 in a position that does not 
clash with the polymerase core and is still consistent with present cryo-EM 
reconstructions (Fernandez-Tornero et al., 2010; Vannini et al., 2010). Such a 
position, in turn, does not agree with the fact that C34 and C31 crosslink to 
distinct sites of C82 (C34 crosslinks to eWH3 and eWH4; C31 crosslinks to 
eWH1 and the coiled coil) but show no crosslinks between each other (Figure 
34B). 
Taken together, the results from crosslinking and mass spectrometry do not 
allow for an accurate placement of the C82/34/31 subcomplex. However, from 
the present results it is likely, that C34 adopts a position similar to that of the 
A49 tWH domain in Pol I (see Chapter 3.5.6) and that of TFIIE (Chen et al., 
2007), with its WH1 facing towards the C160 clamp domain and to C82, and 
the WH2 domain facing towards the C128 side of the central cleft. 
Furthermore, C82 is located above the C160 clamp domain and connects to 
C31, which spans from Rpb5 to C17/C25. These positions agree with 
previous cryo-EM data (Fernandez-Tornero et al., 2010; Vannini et al., 2010). 
However, the large insertions of C82 with respect to human C62, for which 
structural data is available (Lefevre et al., 2011), might lead to a 
rearrangement of the eWH domains which might explain the inconsistencies 
described above. 	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4 Conclusions and Outlook 	  
The aim of this thesis was to characterize Pol I structurally and functionally. 
The use of different experimental approaches led to new insights into the 
architecture of Pol I, revealed the basis for different functional properties of 
the enzyme, and shed light on evolutionary relationships between the three 
eukaryotic transcription systems. 
Despite exhaustive trials, the structure solution of the complete 14-subunit Pol 
I by X-ray crystallography remained unsuccessful for several reasons. The 
reproducibility of suitable crystals for diffraction experiments remained one of 
the major bottlenecks in structure solution by X-ray crystallography. The 
obtained Pol I crystals comprised a huge asymmetric unit that contained 
seven Pol I molecules, which prevented structure solution by molecular 
replacement even though various strategies, such as the use of custom-made 
search models derived from cryo-EM reconstructions from Claus Kuhn, were 
employed. Also, all attempts to solve the crystal structure by isomorphous 
replacement using heavy atom compounds were unsuccessful because those 
compounds either diminished diffraction or, in case of the W18-cluster, could 
not be located at distinct positions in the crystal. Since even small changes on 
the surface of a protein can alter crystal form and crystal quality several 
strategies can be applied in order to produce crystals with a new crystal form, 
better diffraction quality, and less molecules within the asymmetric unit. Initial 
experiments by Christoph Engel showed that complete Pol I from the 
orthologous Schizosaccharomyces pombe (S.p.) can be purified applying a 
purification procedure, which is adapted from the purification protocol used for 
the preparation of Pol I from S.cerevisiae. Also, initial crystals could be 
obtained from S.p. Pol I, but yet need to be reproduced to reach dimensions 
suitable for X-ray diffraction experiments. Along this line, also other yeasts 
such as Pichia pastoris (P.p.) or the thermophilic species Hansenula 
polymorpha (H.p.) could be a good source to obtain crystallization grade Pol I. 
For P.pastoris genetic tools to insert affinity tags are well established. Also in 
case of H. polymorpha genome sequences are available (Ramezani-Rad et 
al., 2003), which enables for genetic manipulations. The use of a thermophilic 
organism, such as H.p., could result in an enzyme, which is more rigid than 
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S.c. Pol I and therefore might lead to a different crystal form or at least better 
diffracting crystals. Manipulations on S.cerevisiae Pol I could also be of use in 
order to obtain a different crystal form. Crosslinking and MS analysis revealed 
an altered jaw domain with a large Pol I-specific insertion in A190 compared 
to Rpb1 in Pol II, which could interfere with potential crystal contacts. 
Removing this insertion as well as another specific insertion in the A190 
clamp head domain could lead to different, Pol II-like, unit cell parameters and 
therefore facilitate structure solution by molecular replacement. Recent 
studies reported the heterologous expression and purification of the core 
factor (Bedwell et al., 2011), part of the Pol I pre-initiation complex. Co-
crystallization experiments with the core factor and Pol I could also lead to a 
new crystal form, which could enable for the solution of the crystallographic 
phase problem. 
After the overall architecture of Pol I was established by cryo-EM (Kuhn et al., 
2007) and the structures of the peripheral subunits, namely A14/43 and 
A49/34.5, were solved by X-ray crystallography (Geiger et al., 2008; Geiger et 
al., 2010) several topological and functional questions remained. These 
questions were addressed by applying a novel technique of protein-protein 
crosslinking and mass spectrometry. Crosslinking-MS data allowed for an 
extension of the previously obtained homology model, confirmed the 
suggested location of the A14/43 subcomplex on the core, and positioned the 
remaining subunit A12.2 and the two domains of the peripheral subcomplex 
A49/34.5 on the core. The position of A12.2 in the pore explains why Pol I 
shows a strong intrinsic cleavage activity compared to the weak intrinsic 
cleavage activity of Pol II and supports the hypothesis that Pol I and Pol III 
differ from Pol II in their mode of RNA cleavage (Ruan et al., 2011). The 
locations of the dimerization module of A49/34.5 and the tWH domain of A49 
are consistent with those of TFIIF and TFIIE on Pol II (Chen et al., 2007; Chen 
et al., 2010) implicating similar functions during transcription. From these 
data, the view emerges that Pol I is evolutionary related to a partial Pol II-
TFIIS-TFIIF-TFIIE complex (Figure 35). The relationship extends to Pol III, 
which contains an A12.2-related subunit, C11, which is also required for RNA 
cleavage (Chedin et al., 1998), a heterodimeric subcomplex, C37/53, which is 
related to TFIIF and A49/34.5 (Kassavetis et al., 2010; Landrieux et al., 2006; 
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Wu et al., 2011), and an additional subcomplex, C82/34/31, which is related to 
TFIIE (Lefevre et al., 2011; Wang and Roeder, 1997). Additionally, 
crosslinking-MS experiments with a Pol I-Rrn3 complex could locate Rrn3 on 
the Pol I surface, spanning from the stalk subunits A14/43 to the dock domain 
of A190. 
 
 
Figure 35. Domain architecture of the complete 14-subunit Pol I. The core enzyme is 
shown as transparent grey surface. The Pol II jaw domain, which is altered in Pol I, is 
depicted as transparent cyan surface. The A14/43 heterodimer adopts a position similar to 
Rpb4/7, as suggested before (Kuhn et al., 2007). The A12.2 N- and C-ribbon (orange) were 
modeled on the jaw/lobe and into the pore, respectively, based on the locations of the N-
ribbon of Rpb9 and the C-ribbon of TFIIS. The A12.2 linker is indicated by a dashed line. The 
A49/A34.5 dimerization module (A49 and A34.5 colored in slate blue and light pink, 
respectively) is located on the lobe of A135, corresponding to the location of the TFIIF 
dimerization module (Chen et al., 2010). The A49 tWH domain (blue) resides over the cleft 
and is apparently mobile. 
 
The results obtained by crosslinking and mass spectrometry prove that this 
method is very valuable to study multi-protein complexes and thus might be 
employed in future studies on the Pol I transcription machinery. Crosslinking-
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MS, for example, could help to yield topological insights into the core factor, 
comprising subunits Rrn6, Rrn7 and Rrn11 (Lin et al., 1996), and its 
interactions with Pol I. Crosslinking-MS is also a valid tool to assist cryo-EM 
investigations since it enables for better domain assignments using low-
resolution EM data. Also EM at high resolutions can profit from validation by 
crosslinking and mass spectrometry, as in these reconstructions mobile parts 
of proteins often get blurred or disappear. Taken together, the work described 
here confirms that crosslinking coupled to mass spectrometry can be a 
powerful tool to study protein-protein interactions of multi-protein complexes 
and even larger functional assemblies in cells. 	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VI Appendix 	  
VI.1 Alignments of subunits in Pol I and their homologs in Pol II 	  
The alignment is taken from Kuhn et al. 2007. Regions previously 
assigned to be of conserved fold are underlined and marked green. 
Additional regions of conserved fold derived from crosslinking and MS 
analysis are depicted in cyan (A-B cross-links) and yellow (B*-B 
crosslinks). All lysin residues involved in crosslinks are bold. Additional 
regions of conserved fold might exist but cannot be predicted with 
certainty. 
 
A190-Rpb1 edited by hand according to 3D structure, EM density and crosslinking-MS 
 
 
A190      ---MDISKPVGSEITSVDFGILTAKEIRNLSAKQITNPTVLDNLG-HPVSGGLYDLALGA 56 
Rpb1      MVGQQYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPETMDETQTRAKIGGLNDPRLGS 60 
                *         * **     * *  *   *  *   *        *** *  **  
 
A190      FLRNL-CSTCGLDEKFCPGHQGHIELPVPCYNPLFFNQLYIYLRASCLFCHHFRLKSVE- 114 
Rpb1      IDRNLKCQTCQEGMNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHNE 120 
            *** * **      **** *** *  *     *           *  *    *      
 
A190      VHRYACKLRLLQYGLIDESYKLDEITLGSLNSSMYTDDEAIEDNEDEMDGEGSKQSKDISS 175 
Rpb1      LMRQALAIKDSKKRFAAIWTLCKTKMVCE-------------------------------- 149 
            * * *                                                        
 
A190      TLLNELKSKRSEYVDMAIAKALSDGRTTERGSFTATVNDERKKLVHEFHKKLLSRGKCDN 235 
Rpb1      -----------------------------------------TDVPSE--DDPTQLVSRGG 166 
                                                        *                   
 
A190      CGMFSPKFRKDGFTKIFETALNEKQITNNRVKGFIRQDMIKKQKQAKKLDGSNEASANDE 295 
Rpb1      CGNTQPTIRKDGLKLVGS------------------------------------------ 184 
          **   *  ****                                                  
 
A190      ESFDVGRNPTTRPKTGSTYILSTEVKNILDTVFRKEQCVLQYVFHSRPNLSRKLVKADSF 355 
Rpb1      ----------WKKDRATGDADEPELRVLSTEEILNIFKHISVKDFTSLGFNEVFSRPEWM 234 
                                 *                                         
 
A190      FMDVLVVPPTRFRLPSKLGEEVHENSQNQLLSKVLTTSLLIRDLNDDLSKLQKDKVSLED 415 
Rpb1      ILTCLPVPPPPVRPSISFNESQRG---EDDLTFKLADILKANISLETLEHNGAP------ 285 
              * ***   *      *          *   *   *        *           
 
A190      RRVIFSRLMNAFVTIQNDVNAFIDSTKAQG-RTSGKVPIPGVKQALEKKEGLFRKHMMGKR 475 
Rpb1      --HHAIEEAESLLQFHVATYMDNDIAGQPQALQKSGRPVKSIRARLKGKEGRIRGNLMGKR 344 
                                 *             *       *  ***  *   **** 
 
A190      VNYAARSVISPDPNIETNEIGVPPVFAVKLTYPEPVTAYNIAELRQAVINGPDKWPGATQ 535 
Rpb1      VDFSARTVISGDPNLELDQVGVPKSIAKTLTYPEVVTPYNIDRLTQLVRNGPNEHPGAKY 404 
          *   ** *** *** *    ***   *  ***** ** ***  * * * ***   ***   
 
A190      IQNEDGSLVSLIGMSVEQRKALANQLLTPSSNVSTHTLNKKVYRHIKNRDVVLMNRQPTL 595 
Rpb1      VIRDSGDRIDLR--------------YSKRAGDIQLQYGWKVERHIMDNDPVLFNRQPSL 450 
               *    *                             ** ***   * ** **** * 
 
A190      HKASMMGHKVRVLPNEKTLRLHYANTGAYNADFDGDEMNMHFPQNENARAEALNLANTDS 655 
Rpb1      HKMSMMAHRVKVIPYS-TFRLNLSVTSPYNADFDGDEMNLHVPQSEETRAELSQLCAVPL 509 
          ** *** * * * *   * **    *  *********** * ** *  ***   *      
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A190      QYLTPTSGSPVRGLIQDHISAGVWLTSKDSFFTREQYQQYIYGCIRPEDGHTTRSKIVTL 715 
Rpb1      QIVSPQSNKPCMGIVQDTLCGIRKLTLRDTFIELDQVLNMLYWVPDWDG--------VIP 561 
          *   * *  *  *  **       **  * *    *     *               *   
 
A190      PPTIFKPYPLWTGKQIITTVLLNVTPPDMPGINLISKNKIKNEYWGKGSLENEVLFKDGA 775 
Rpb1      TPAIIKPKPLWSGKQILSVAIP----------NGIHLQRFDEGTTLLSPKDNGMLIIDGQ 611 
           * * ** *** ****                * *                *  *  **  
 
A190      LLCGILDKSQYGASKYGIVHSLHEVYGPEVAAKVLSVLGRLFTNYITATAFTCGMDDLRL 835 
Rpb1      IIFGVVEKKTVGSSNGGLIHVVTREKGPQVCAKLFGNIQKVVNFWLLHNGFSTGIGDT-- 669 
             *   *   * *  *  *      ** * **                 *  *  *    
 
A190      TAEGNKWRTDILKTSVDTGREAAAEVTNLDKDTPADDPELLKRLQEILRDNNKSGILDAV 895 
Rpb1      -----IADGPTMREITETIAEAKKKVLDVTKEAQAN-----------LLTAKHGMTLRES 713 
                           *  **   *    *   *            *        *    
 
A190      TSSKVNAITSQVVSKCVPDGTMKKFPCNSMQAMALSGAKGSNVNVSQIMCLLGQQALEGR 955 
Rpb1      FEDNVVRFLNEARDKAGRLAEVNLKDLNNVKQMVMAGSKGSFINIAQMSACVGQQSVEGK 773 
              *         *            *    *   * ***  *  *     ***  **  
 
A190      RVPVMVSGKTLPSFKPYETDAMAGGYVKGRFYSGIKPQEYYFHCMAGREGLIDTAVKTSR 1015 
Rpb1      RIAFGFVDRTLPHFSKDDYSPESKGFVENSYLRGLTPQEFFFHAMGGREGLIDTAVKTAE 833 
          *        *** *          * *      *  ***  ** * ************   
 
A190      SGYLQRCLTKQLEGVHVSYDNSIRDADGTLVQFMYGGDAIDITKESHMTQFEFCLDNYYA 1075 
Rpb1      TGYIQRRLVKALEDIMVHYDNTTRNSLGNVIQFIYGEDGMDAAHIEKQ-SLDTIGGSDAA 892 
           ** ** * * **   * ***  *   *   ** ** *  *                  * 
 
A190      LLKKY------------------------------------------------------- 1080 
Rpb1      FEKRYRVDLLNTDHTLDPSLLESGSEILGDLKLQVLLDEEYKQLVKDRKFLREVFVDGEA 952 
            * *                   *     *     *    * *    *         *  
 
 
A190      -------NPSALIEHLDVESALKYSKKTLKYRKKHSKEPHYKQSVKYDPVLAKYNPAKYL 1133 
Rpb1      NWPLPVNIRRIIQNAQQTFHIDHTKPSDLTIKDIVLGVKDLQENLLVLRGKNEIIQNAQR 1012 
                                                                            
 
A190      GSVSENFQDKLESFLDKNSKLFKSSDGVNEKKFRALMQLKYMRSLINPGEAVGIIASQSV 1193 
Rpb1      DAVTLFCCLLRSRLATRRVLQEYRLTKQAFDWVLSNIEAQFLRSVVHPGEMVGVLAAQSI 1072 
            *                                       **   *** **  * **  
 
A190      GEPSTQMTLNTFHFAGHGAANVTLGIPRLREIVMTASAAIKTPQMTLPIWN--DVSDEQA 1251 
Rpb1      GEPATQMTLNTFHFAGVASKKVTSGVPRLKEILN-VAKNMKTPSLTVYLEPGHAADQEQA 1131 
          *** ************     ** * *** **        ***  *           *** 
 
A190      DTFCKSISKVLLSEVIDKVIVTETTGTSNTAGGNAARSYVIHMRFFDNNEYSEEYDVSKE 1311 
Rpb1      KLIRSAIEHTTLKSVTIASEIYYDPDPRSTVIPEDEEIIQLHFSLLDEEAEQSFDQQSPW 1191 
                *    *  *              *           *    *          *   
 
A190      ELQNVISNQFIHLLEAAIVKEIKKQKRTTGPDIGVAVPRLQTDVANSSSNSKRLEEDNDE 1371 
Rpb1      LLRLELDRAAMNDKDLTMGQVGERIKQTFKNDLFVIWSEDNDEKLIIRCRVVRPKSLDAE 1251 
           *                       * *   *  *                 *      * 
 
A190      EQSHKKTKQAVSYDEPDEDEIETMREAEKSSDEEGIDSDKESDSDSEDEDVDMNEQINKS 1431 
Rpb1      TEAEEDHMLKKIENTMLENITLR------------------------------------- 1274 
                           *         
 
A190      IVEANNNMNKVQRDRQSAIISHHRFITKYNFDDESGKWCEFKLELAADTEKLLMVNIVEE 1491 
Rpb1      --------------------------------------------------------GVEN 1278 
                                                                   ** 
 
A190      ICRKSIIRQIPHIDRCVHPEPENGKRVLVTEGVNFQAMWDQEAFIDVDGITSNDVAAVLK 1551  
Rpb1      IERVVMMKYDRKVPSPTGEYVKEPEWVLETDGVNLSEVMTVPG-IDPTRIYTNSFIDIME 1337 
          * *                       ** * ***          **   *  *  
 
A190      TYGVEAARNTIVNEINNVFSRYAISVSFRHLDLIADMMTRQGTYLAFNRQGMETS-TSSF 1610 
Rpb1      VLGIEAGRAALYKEVYNVIASDGSYVNYRHMALLVDVMTTQGGLTSVTRHGFNRSNTGAL 1398 
            * ** *     *  **       *  **  *  * ** **      * *   * * 
 
A190      MKMSYETTCQFLTKAVLDNEREQLDSPSARIVVGKLNNVGTGSFDVLAKVPNAA-- 1664 
Rpb1      MRCSFEETVEILFEAGASAELDDCRGVSENVILGQMAPIGTGAFDVMIDEESLVKY 1453 ->CTD 
          *  * * *   *  *    *       *     *     *** *** 
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A135-Rpb2 edited by hand according to 3D structure, EM density and crosslinking-MS 
 
 
A135      MSKVIKPPGQARTADFRTLERESRFINPPKDKSAFPLLQEAVQPHIGSFNALTEGPDGGL 60 
Rpb2      MSDLANSE-KYYDEDPYGFEDESAPITAEDSWAVISAFFREKGLVSQQLDSFNQFVDYTL 59 
          **            *    * **  *                              *  * 
 
A135      LNLGVKDIGEKVIFDGKPLNSEDEISNSGYLGNKLSVSVEQVSIAKPMSNDGVSSAVERK 120 
Rpb2      QDIICEDS--TLILEQLAQHTTE----SDNISRKYEISFGKIYVTKPMVNE--SDGVTHA 111 
                *     *              *     *   *       *** *   *  *    
 
A135      VYPSESRQRLTSYRGKLLLKLKWSVNN-----GEENLFEVRD-------------CGGLP 162 
Rpb2      LYPQEARLRNLTYSSGLFVDVKKRTYEAIDVPGRELKYELIAEESEDDSESGKVFIGRLP 171 
           ** * * *   *   *    *          * *   *                 * ** 
 
A135      VMLQSNRCHLNKMSPYELVQHKEESDEIGGYFIVNGIEKLIRMLIVQRRNHPMAIIRPSF 222 
Rpb2      IMLRSKNCYLSEATESDLYKLKECPFDMGGYFIINGSEKVLIAQERSAGNIVQVFKKAAP 231 
           ** *  * *       *   **     ***** ** **          *         
 
A135      ANRGASYSHYGIQIRSVRPDQTSQTNVLHYLNDGQVTFRFSWRKNEYLVPVVMILKALCH 282 
Rpb2      SPISHVAEIRSALEKGSRFISTLQVKLYGREGSSARTIKATLPYIKQDIPIVIIFRALGI 291 
                           *   * *            *            * * *  **   
 
A135      TSDREIFDGIIGNDVKDSFLTDRLELLLRGFKKRYPHLQNRTQVLQYLGDKFRVVFQASP 342 
Rpb2      IPDGEILEHIC-YDVNDWQMLEMLKPCVEDG----FVIQDRETALDFIGR--RGTALGIK 344 
            * **   *   ** *      *              * *   *   *   *        
 
A135      DQSDLEVGQEVLDRIVLVHLGKDG--SQDKFRMLLFMIRKLYSLVAGECSPDNPDATQHQ 400 
Rpb2      KEKRIQYAKDILQKEFLPHITQLEGFESRKAFFLGYMINRLLLCALDRKDQDDRDHFGKK 404 
                     *    * *          *   *  **  *          *  *      
 
A135      EVLLGGFLYGMILKEKIDEYLQNIIAQVRMDINRGMAINFKDKRYMSRVLMRVNENIGSK 460 
Rpb2      RLDLAGPLLAQLFKTLFKKLTKDIFRYMQRTVEEAHDFNMK--------LAINAKTITSG 456 
             * * *     *         *              * *        *      * *  
 
A135      MQYFLSTGNLVSQSGLDLQQVSGYTVVAEKINFYRFISHFRMVHRGSFFAQLKTTTVRKL 520 
Rpb2      LKYALATGNWGEQK-KAMSSRAGVSQVLNRYTYSSTLSHLRRTN-TPIGRDGKLAKPRQL 514 
            * * ***   *         *   *          ** *           *    * * 
 
A135      LPESWGFLCPVHTPDGSPCGLLNHFAHKCRISTQQSDVSRIPSILYSLGVAPASHTFAAG 580 
Rpb2      HNTHWGLVCPAETPEGQACGLVKNLSLMSCISVG-TDPMPIITFLSEWGMEPLEDYVPHQ 573 
              **  **  ** *  ***         **    *   *   *   *  *         
 
A135      -PSLCCVQIDGKIIGWVSHEQGKIIADTLRYWKVEGKTPGLPIDLEIG----YVPPSTRGQ- 636 
Rpb2      SPDATRVFVNGVWHGV--HRNPARLMETLRTLRRKGDINPEVSMIRDIREKELKIFTDAGRV 633 
                *   *   *   *        ***     *                       * 
 
A135      YPGLYLFGG---------HSRMLRPVRYLPLDK-----------------------EDIV 662 
Rpb2      YRPLFIVEDDESLGHKELKVRKGHIAKLMATEYQDIEGGFEDVEEYTWSSLLNEGLVEYI 693 
          *  *                *                                           
 
A135      GPFEQVYMNIAVTPQEIQ-----------------------NNVHTHVEFTPTNILSILA 701 
Rpb2      DAEEEESILIAMQPEDLEPAEANEENDLDVDPAKRIRVSHHATTFTHCEIHPSMILGVAA 753 
             *     **  *                               ** *  *  **   * 
 
A135      NLTPFSDFNQSPRNMYQCQMGKQTMGTPGVALCHRSDNKLYRLQTGQTPIVKANLYDDYG 761 
Rpb2      SIIPFPDHNQSPRNTYQSAMGKQAMGVFLTNYNVRMDTMANILYYPQKPLGTTRAMEYLK 813 
             ** * ****** **  **** **        * *     *   * *            
 
A135      MDNFPNGFNAVVAVISYTGYDMDDAMIINKSADERGFGYGTMYKTEK-VDLALNRNRGDP 820 
Rpb2      FRELPAGQNAIVAIACYSGYNQEDSMIMNQSSIDRGLFRSLFFRSYMDQEKKYGMSITET 873 
              * * ** **   * **   * ** * *   **    
 
A135      ITQHFGFGNDEWPKEWLEKLDEDGLPYIGTYVEEGDPICAYFDDT-------LNKTKIKT 873 
Rpb2      FEKPQRTNTLRMKHGTYDKLDDDGLIAPGVRVSGEDVIIGKTTPISPDEEELGQRTAYHS 933 
                            *** ***   *  *   * *                 *    
 
A135      YHSSEPAYIEEVNLIGDESNKFQE---LQTVSIKYRIRRTPQIGDKFSSRHGQKGVCSRK 930 
Rpb2      KRDASTPLRSTENGIVDQVLVTTNQDGLKFVKVRVRTTKIPQIGDKFASRHGQKGTIGIT 993 
                      * * *          *  *    *    ******* ******* 
 
 
A135      WPTIDMPFSETGIQPDIIINPHAFPSRMTIGMFVESLAGKAGALHGIAQDSTPWIFNEDD 990 
Rpb2      YRREDMPFTAEGIVPDLIINPHAIPSRMTVAHLIECLLSKVAALSGNEGDASPFT----D 1049 
              ****   ** ** ****** *****     * *  *  ** *   *  *      * 
 
A135      TPADYFGEQLAKAGYNYHGNEPMYSGATGEELRADIYVGVVYYQRLRHMVNDKFQVRSTG 1050 
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Rpb2      ITVEGISKLLREHGYQSRGFEVMYNGHTGKKLMAQIFFGPTYYQRLRHMVDDKIHARARG 1109 
                   *   **   * * ** * **  * * *  *  ********* **   *  * 
 
A135      PVNSLTMQPVKGRKRHGGIRVGEMERDALIGHGTSFLLQDRLLNSSDYTQASVCRECGSI 1110 
Rpb2      PMQVLTRQPVEGRSRDGGLRFGEMERDCMIAHGAASFLKERLMEASDAFRVHICGICGLM 1169 
          *   ** *** ** * ** * ******  * **    *  **   **      *  **   
 
A135      LTTQQSVPRIGSISTVCCRRCSMRFEDAKKLLTKSEDGEKIFIDDSQIWEDGQGNKFVGG 1170 
Rpb2      TVIAKLN-----HNQFECKGCDN------------------------------------K 1188 
                           *  *                                        
 
A135      NETTTVAIPFVLKYLDSELSAMGIRLRYNVEPK--- 1203 
Rpb2      IDIYQIHIPYAAKLLFQELMAMNITPRLYTDRSRDF 1224 
                 **   * *  ** ** *  *    
 
 
 	  
  Appendix	  
	   XIII	  
AC40-Rpb3 edited by hand according to 3D structure, EM density and crosslinking-MS 
 
 
 
AC40      MSNIVGIEYNRVTNTTSTDFPGFSKDAENEWNVEKFKKDFEVNISSLDAREANFDLINID 60 
Rpb3      ----------------------------------MSEEGPQVKIREASKDNVDFILSNVD 26 
                                                   * *         * * * * 
 
AC40      TSIANAFRRIMISEVPSVAAEYVYFFNNTSVIQDEVLAHRIGLVPLK-VDPDMLTWVDSN 119 
Rpb3      LAMANSLRRVMIAEIPTLAIDSVEVETNTTVLADEFIAHRLGLIPLQSMDIEQLEYSRDC 86 
             **  ** ** * *  *   *    ** *  **  *** ** **   *   *       
 
AC40      LPDDEKFTDENTIVLSLNVKCTRNPDAPKGSTDPKELYNNAHVYARDLKFEPQGRQSTTF 179 
Rpb3      FCED--HCDKCSVVLTLQAFGESE--------------STTNVYSKDLVIVSNLMGRNIG 130 
             *    *    ** *                         **  **             
 
AC40      ADCPVVPADPDILLAKLRPGQEISLKAHCILGIGGDHAKFSPVSTASYRLLPQINILQPI 239 
Rpb3      HPIIQDKEGNGVLICKLRKGQELKLTCVAKKGIAKEHAKWGPAAAIEFEYDPWNKLKH-- 188 
                      *  *** ***  *      **   ***  *         *       
 
AC40      KGESARRFQKCFPPGVIGIDEGSDEAYVKDARKDTVSREVLRYEEFADK---VKLGRVRN 296 
Rpb3      ----------------------TDYWYEQDSAKEWPQSKNCEYEDPPNEGDPFDYKAQAD 226 
                                 *  *  *  *         **  
 
AC40      HFIFNVESAGAMTPEEIFFKSVRILKNKAEYLKNCPITQ--------------------- 335 
Rpb3      TFYMNVESVGSIPVDQVVVRGIDTLQKKVASIL-LALTQMDQDKVNFASGDNNTASNMLG 282 
           *  **** *              *  *         **   
 
AC40      --------------------------------- 356 
Rpb3      SNEDVMMTGAEQDPYSNASQMGNTGSGGYDNAW 318 
 
 
 
AC19-Rpb11 edited by hand according to 3D structure, EM density and crosslinking-MS 
 
 
AC19      MTEDIEQKKTATEVTPQEPKHIQEEEEQDVDMTGDEEQEEEPDREKIKLLTQATSEDGTS 60 
Rpb11     ------------------------------MNAPDRFELFLLGEGESKLKIDPDTKAPNA 30 
                                            *            **     
 
AC19       ASFQIVEEDHTLGNALRYVIMKNPDVEFCGYSIPHPSENLLNIRIQTYGETTAVDALQKG 120 
Rpb11      VVITFEKEDHTLGNLIRAELLNDRKVLFAAYKVEHPFFARFKLRIQTTEGYDPKDALKNA 90 
                  *******  *        * *  *   **       ****       ***    
 
AC19       LKDLMDLCDVVESKFTEKIKSM-------- 142 
Rpb11      CNSIINKLGALKTNFETEWNLQTLAADDAF 120 
                         *  
 
 
 
 
A12.2-Rpb9 edited by hand according to 3D structure, EM density and crosslinking-MS 
 
 
 
A12.2      MSVVGSLIFCLDCGDLLENPNAVLG---SNVECSQCKAIYPKSQFSNLKVVTTTADDAFPSSLRAKKSVVKTSL 71 
Rpb9       ---MTTFRFCRDCNNMLY-PREDKENNRLLFECRTCSYVEEAGS----------PLVYRHELITNIGETAGVVQ 60 
                   ** **   *  *      *    **  *                                          
 
A12.2      KKNELKDGATIKEKCPQCGNEEMNYHTLQLRSADEGATVFYTCTSCGYKFRTNN-------- 125 
Rpb9       DIGSDPTLPRSDRECPKCHSRENVFFQSQQRRKDTSMVLFFVCLSCSHIFTSDQKNKRTQFS 122 
                         ** *   *      * *  *     *  * **   *    
 
 
 
 
A12.2 C-terminus      -----RAKKSVVKTSLKKNE---LKDGATIKEKCPQCGNEEMNYHTLQLRSADEGATVFY 52 
TFIIS 3rd domain      PAPLKQKIEEIAKQNLYNAQGATIERSVTDRFTCGKCKEKKVSYYQLQTRSADEPLTTFC 60 
                                  *  *            *    *  *      *  ** *****  * *  
 
A12.2 C-terminus      TCTSCGYKFRTNN 65 
TFIIS 3rd domain      TCEACGNRWKFS- 72 
                      **  **	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VI.2 Alignments of subunits in Pol III and their homologs in Pol II 	  
The alignment is taken from Jasiak et al. 2006. Regions previously 
assigned to be of conserved fold are underlined and marked green. 
Additional regions of conserved fold derived from crosslinking and MS 
analysis are depicted in cyan (A-B cross-links) and yellow (B*-B 
crosslinks). All lysin residues involved in crosslinks are bold. Additional 
regions of conserved fold might exist but cannot be predicted with 
certainty. 	  
Rpb1-C160 (Rpc1) 
 
Rpb1      MVGQQYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPETMDETQTRAKIG-GLNDPRLG 59 
C160      -MKEVVVSETPKRIKGLEFSALSAADIVAQSEVEVSTRDLFDLEKDRAPKANGALDPKMG 59 
           : :   * . : :* ::*. :*. :: * * .::   : :*  : **  . *  **::* 
 
Rpb1      SIDRNLKCQTCQEGMNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHN 119 
C160      VSSSSLECATCHGNLASCHGHFGHLKLALPVFHIGYFKATIQILQGICKNCSAILLSETD 119 
            . .*:* **: .: .* *****:.** ****:*::    :: : :* :*. :**.* : 
 
Rpb1      ------ELMRQALAIKDSKKRFAAIWTLCKTKMVCETDVPSEDDPTQLVSRGGCGNTQPT 173 
C160      KRQFLHELRRPGVDNLRRMGILKKILDQCKKQRRCLHCGALNG--VVKKAAAGAGSAALK 177 
                ** * .:        :  *   **.:  *    . :....   : .*.*.:  . 
 
Rpb1      IRKDGLKLVG--------SWKKDRATGDADEPELR--------VLSTEEILNIFKHISVK 217 
C160      IIHDTFRWVGKKSAPEKDIWVGEWKEVLAHNPELERYVKRCMDDLNPLKTLNLFKQIKSA 237 
          * :* :: **         *  :     *.:***.         *.. : **:**:*.   
 
Rpb1      DFTSLGFNEVFS--RPEWMILTCLPVPPPPVRPSISFNES-QRGEDDLTFKLADILKANI 274 
C160      DCELLGIDATVPSGRPETYIWRYLPAPPVCIRPSVMMQDSPASNEDDLTVKLTEIVWTSS 297 
          *   **:: ...  ***  *   **.**  :***: :::*   .*****.**::*: :.  
 
Rpb1      SLETLEHNGAPHHAIEEAESLLQFHVATYMDNDIAGQPQALQKSG-----RPVKSIRARL 329 
C160      LIKAGLDKGISINNMMEHWDYLQLTVAMYINSDSVNPAMLPGSSNGGGKVKPIRGFCQRL 357 
           :::  .:* . : : *  . **: ** *::.* .. .    .*.     :*::.:  ** 
 
Rpb1      KGKEGRIRGNLMGKRVDFSARTVISGDPNLELDQVGVPKSIAKTLTYPEVVTPYNIDRLT 389 
C160      KGKQGRFRGNLSGKRVDFSGRTVISPDPNLSIDEVAVPDRVAKVLTYPEKVTRYNRHKLQ 417 
          ***:**:**** *******.***** ****.:*:*.**. :**.***** ** ** .:*  
 
Rpb1      QLVRNGPNEHPGAKYVIR-DSGDRIDLRYSKRAGDIQ-LQYGWKVERHIMDNDPVLFNRQ 447 
C160      ELIVNGPNVHPGANYLLKRNEDARRNLRYGDRMKLAKNLQIGDVVERHLEDGDVVLFNRQ 477 
          :*: **** ****:*::: :.. * :***..*    : ** *  ****: *.* ****** 
 
Rpb1      PSLHKMSMMAHRVKVIPYSTFRLNLSVTSPYNADFDGDEMNLHVPQSEETRAELSQLCAV 507 
C160      PSLHRLSILSHYAKIRPWRTFRLNECVCTPYNADFDGDEMNLHVPQTEEARAEAINLMGV 537 
          ****::*:::* .*: *: ***** .* :*****************:**:***  :* .* 
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Rpb1      PLQIVSPQSNKPCMGIVQDTLCGIRKLTLRDTFIELDQVLNMLYWVPD--WDGVIPTPAI 565 
C160      KNNLLTPKSGEPIIAATQDFITGSYLISHKDSFYDRATLTQLLSMMSDGIEHFDIPPPAI 597 
            ::::*:*.:* :. .** : *   :: :*:* :   : ::*  :.*   .  **.*** 
 
Rpb1      IKPKPLWSGKQILSVAIP---NGIHLQRFDEGTTLLSP-----------KDNGMLIIDG- 610 
C160      MKPYYLWTGKQVFSLLIKPNHNSPVVINLDAKNKVFVPPKSKSLPNEMSQNDGFVIIRGS 657 
          :**  **:***::*: *    *.  : .:*  ..:: *           :::*::** *  
 
Rpb1      QIIFGVVEKKTVGSSN-GGLIHVVTREKGPQVCAKLFGNIQKVVNFWLLHNGFSTGIGDT 669 
C160      QILSGVMDKSVLGDGKKHSVFYTILRDYGPQEAANAMNRMAKLCARFLGNRGFSIGINDV 717 
          **: **::*..:*..:  .:::.: *: *** .*: :..: *:   :* :.*** **.*. 
 
Rpb1      IADGPTMREITETIAEAKKKVLDVTKEAQANLLTAKHGMTLRESFEDNVVRFLNEARDKA 729 
C160      TPADDLKQKKEELVEIAYHKCDELITLFNKGELETQPGCNEEQTLEAKIGGLLSKVREEV 777 
           . .   ::  * :  * :*  :: .  : . * :: * . .:::* ::  :*.:.*::. 
 
Rpb1      GRLAEVNLKDLNNVKQMVMAGSKGSFINIAQMSACVGQQSVEGKRIAFGFVDRTLPHFSK 789 
C160      GDVCINELDNWNAPLIMATCGSKGSTLNVSQMVAVVGQQIISGNRVPDGFQDRSLPHFPK 837 
          * :.  :*.: *    *. .***** :*::** * **** :.*:*:. ** **:****.* 
 
Rpb1      DDYSPESKGFVENSYLRGLTPQEFFFHAMGGREGLIDTAVKTAETGYIQRRLVKALEDIM 849 
C160      NSKTPQSKGFVRNSFFSGLSPPEFLFHAISGREGLVDTAVKTAETGYMSRRLMKSLEDLS 897 
          :. :*:*****.**:: **:* **:***:.*****:***********:.***:*:***:  
 
Rpb1      VHYDNTTRNSLGNVIQFIYGEDGMDAAHIEKQSLDTIGGSDAAFEKRYRVDLLNTDHTLD 909 
C160      CQYDNTVRTSANGIVQFTYGGDGLDPLEMEGNAQPVN--FNRSWDHAYNITFNNQDKGLL 955 
           :****.*.* ..::** ** **:*. .:* ::  . .. : :::: *.: : * *: *  
 
Rpb1      P-SLLESGSEILGDLKLQVLLDEEYKQLVKDRKFLREVFVDGEANWPLPVNIRRIIQNAQ 968 
C160      PYAIMETANEILGPLEERLVRYDNSGCLVKREDLNKAEYVD------QYDAERDFYHSLR 1009 
          * :::*:..**** *: :::  ::   *** ..: :  :**..:. . . .     ..:. 
 
 
Rpb1      QTFHIDHTKPSDLTIKDIVLGVKDLQENLLVLRGKNEIIQNAQRDAVTLFCCLLRSRLAT 1028 
C160      EYIN----------------GKATALANLRKSRGMLGLLEPPAKELQGIDPDETVPDNVK 1053 
                              *      **   **   ::: . ::   :      .  .. 
 
Rpb1      RRVLQEYRLTKQAFDWVLSNIEAQFLRSVVHPGEMVGVLAAQSIGEPATQMTLNTFHFAG 1088 
C160      TSVSQLYRISEKSVRKFLEIALFKYRKARLEPGTAIGAIGAQSIGEPGTQMTLKTFHFAG 1113 
            * * **:::::.  .*.    :: :: :.**  :*.:.*******.*****:****** 
 
Rpb1      VASKKVTSGVPRLKEILNVAKNMKTPSLTVYLEPGHAADQEQAKLIRSAIEHTTLKSVTI 1148 
C160      VASMNVTLGVPRIKEIINASKVISTPIINAVLVN--DNDERAARVVKGRVEKTLLSDVAF 1171 
          *** :** ****:***:*.:* :.** :.. *  .   *:. *::::. :*:* *..*:: 
 
Rpb1      ASEIYYDPDPRSTVIPEDEEIIQLHFSLLDEEAEQSFDQQSPWLLRLELDRAAMNDKDLT 1208 
C160      YVQDVYKDN-------------------------LSFIQVRIDLGTIDKLQLELTIEDIA 1206 
            :  *. :. ::  .....  .   :  ...:. ** *    *  ::  :  :. :*: 
 
Rpb1      MGQVGERIKQTFKNDLFVIWSEDNDEKLIIRCRVVRPKSLDAETEAEEDHMLKKIEN-TM 1267 
C160      VAITRASKLKIQASDVNIIGKDRIAINVFPEGYKAKSISTSAKEPSENDVFYRMQQLRRA 1266 
          :. .     :   .*: :* .:    ::: .   .:. * .*:  :*:* : :  :     
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Rpb1      LENITLRGVENIERVVMMKYDRKVPSPTGEYVKEPEWVLETDGVNLSEVMTVPGIDPTRI 1327 
C160      LPDVVVKGLPDISRAVINIRD------------DGKRELLVEGYGLRDVMCTDGVIGSRT 1314 
          * ::.::*: :*.*.*:   * . .:.:..  .: :  * .:* .* :** . *:  :*  
 
Rpb1      YTNSFIDIMEVLGIEAGRAALYKEVYNVIASDGSYVNYRHMALLVDVMTTQGGLTSVTRH 1387 
C160      TTNHVLEVFSVLGIEAARYSIIREINYTMSNHGMSVDPRHIQLLGDVMTYKGEVLGITRF 1374 
           ** .::::.******.* :: :*:  .::..*  *: **: ** **** :* : .:**. 
 
 
 
Rpb1      GFNRSNTGALMRCSFEETVEILFEAGASAELDDCRGVSENVILGQMAPIGTGAFDVMIDE 1447 
C160      GLSKMRDSVLQLASFEKTTDHLFDAAFYMKKDAVEGVSECIILGQTMSIGTGSFKVVKG- 1433 
          *:.: . ..*  .***:*.: **:*.   : *  .**** :****  .****:*.*: .  
 
 
 
Rpb1      ESLVKYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGG 1507 
C160      ----------------------------------TNISEKDLVPKRCLFESLSNEAALKA 1459 
                                            :::. ** :    *.:* **:*   . 
 
Rpb1      FTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTS 1567 
C160      N----------------------------------------------------------- 1467 
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Rpb2-C128 (Rpc2) 
 
Rpb2      ---MSDLANSEKYYDEDPYGFEDESAPI-----------TAEDSWAVISAFFREKGLVSQ 46 
C128      MVAATKRRKTHIHKHVKDEAFDDLLKPVYKGKKLTDEINTAQDKWHLLPAFLKVKGLVKQ 60 
              :.  ::. : . .  .*:*   *:            *:*.* ::.**:: ****.* 
 
Rpb2      QLDSFNQFVDYTLQDIICEDSTLILEQLAQHTTESDNISRKYEISFGKIYVTKPMVNESD 106 
C128      HLDSFNYFVDTDLKKIIKAN-------------QLILSDVDPEFYLKYVDIRVGKKSSSS 107 
          :***** ***  *:.**  :                                    ..*. 
 
Rpb2      GVTHALYPQEARLRNLTYSSGLFVDVKKRTYEAIDVPGRELKYELIAEESEDDSESGKVF 166 
C128      TKDYLTPPHECRLRDMTYSAPIYVDIEYTR-------GR----NIIMHKD--------VE 148 
             :   *:*.***::***: ::**::          **    ::* .:.        *  
 
Rpb2      IGRLPIMLRSKNCYLSEATESDLYKLKECPFDMGGYFIINGSEKVLIAQERSAGNIVQVF 226 
C128      IGRMPIMLRSNKCILYDADESKMAKLNECPLDPGGYFIVNGTEKVILVQEQLSKNRIIVE 208 
          ***:******::* * :* **.: **:***:* *****:**:***::.**: : * : *  
 
Rpb2      KKAAPSPISHVAEIRSALEKGSRFISTLQVKLYGREGSSARTIKATLPYIKQDIPIVIIF 286 
C128      ADEKK--GIVQASVTSS—THERKSKTYVITKNGK--------IYLKHNSIAEEIPIAIVL 257 
           .   .     *                  *           *      * ::***.*:: 
 
Rpb2      RALGIIPDGEILEHICYDVNDWQMLEMLKPCVEDGFVIQDRETALDFIGRRGTALGIKKE 346 
C128      KACGILSDLEIMQLVCGNDSSYQDIFAVNLEESSKLDIYTQQQALEYIGAKVKTMRRQKL 317 
          :* **:.* **:: :* : ..:* :  ::   .. : *  :: **::** : .::  :*  
 
Rpb2      KRIQYAKDILQKEFLPHITQLEGFESRKAFFLGYMINRLLLCALDRKDQDDRDHFGKKRL 406 
C128      TILQEGIEAIATTVIAHLTVEALDFREKALYIAMMTRRVVMAMYNPKMIDDRDYVGNKRL 377 
          . :* . : : . .:.*:*       .**:::. * .*:::.  : *  ****:.*:*** 
 
Rpb2      DLAGPLLAQLFKTLFKKLTKDIFRYMQRTVEEAH---DFNMKLAINAKT--ITSGLKYAL 461 
C128      ELAGQLISLLFEDLFKKFNNDFKLSIDKVLKKPNRAMEYDALLSINVHSNNITSGLNRAI 437 
          :*** *:: **: ****:.:*:   :::.:::.:   :::  *:**.::  *****: *: 
 
Rpb2      ATGNWGEQKKAMSSRAGVSQVLNRYTYSSTLSHLRRTNTPIGRDGKLAKPRQLHNTHWGL 521 
C128      STGNWS-LKRFKMERAGVTHVLSRLSYISALGMMTRISSQFEKSRKVSGPRALQPSQFGM 496 
          :****.  *:   .****::**.* :* *:*. : * .: : :. *:: ** *: :::*: 
 
Rpb2      VCPAETPEGQACGLVKNLSLMSCISVGTDPMPIITFLSEWGMEPLEDYVPHQSPDATRVF 581 
C128      LCTADTPEGEACGLVKNLALMTHITTDDEEEPIKKLCYVLGVEDITLIDSASLHLNYGVY 556 
          :*.*:****:********:**: *:.. :  ** .:    *:* :    . .      *: 
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Rpb2      VNGVWHGVHRNPARLMETLRTLRRKGDINPEVSMIRDIREKELKIFTDAGRVYRPLFIVE 641 
C128      LNGTLIGSIRFPTKFVTQFRHLRRTGKVSEFISIYSNSHQMAVHIATDGGRICRPLIIVS 616 
          :**.  *  * *::::  :* ***.*.:.  :*:  : ::  ::* **.**: ***:**. 
 
Rpb2      DDESLGHKELKVRKGHIAKLMATEYQDIEGGFEDVEEYTWSSLLNEGLVEYIDAEEEESI 701 
C128      DGQSR------VKDIHLRKLLD-------------GELDFDDFLKLGLVEYLDVNEENDS 657 
          *.:*       *:. *: **:               *  :..:*: *****:*.:**:.  
 
 
Rpb2      LIAMQPEDLEPAEANEENDLDVDPAKRIRVSHHATTFTHCEIHPSMILGVAASIIPFPDH 761 
C128      YIALYEKDIVP------------------------SMTHLEIEPFTILGAVAGLIPYPHH 693 
           **:  :*: *                        ::** **.*  ***..*.:**:*.* 
 
Rpb2      NQSPRNTYQSAMGKQAMGVFLTNYNVRMDTMANILYYPQKPLGTTRAMEYLKFRELPAGQ 821 
C128      NQSPRNTYQCAMGKQAIGAIAYNQFKRIDTLLYLMTYPQQPMVKTKTIELIDYDKLPAGQ 753 
          *********.******:*.:  *   *:**:  :: ***:*: .*:::* :.: :***** 
 
Rpb2      NAIVAIACYSGYNQEDSMIMNQSSIDRGLFRSLFFRSYMDQEKKYGMSITETFEKPQRTN 881 
C128      NATVAVMSYSGYDIEDALVLNKSSIDRGFGRCETRRKTTTVLKRYANHTQDIIGG-MRVD 812 
          ** **: .****: **::::*:******: *.   *.     *:*.    : :    *.: 
 
Rpb2      TLRMKHGTYDKLDDDGLIAPGVRVSGEDVIIGKTTPIS-PDEEELGQRTAYHSKRDASTP 940 
C128      ENGDPIWQHQSLGPDGLGEVGMKVQSGQIYINKSVPTNSADAPNPNNVNVQTQYREAPVI 872 
                  ::.*. ***   *::*.. :: *.*:.* . .*  : .: ..  . *:*..  
 
Rpb2      LRSTENGIVDQVLVTTNQDGLKFVKVRVRTTKIPQIGDKFASRHGQKGTIGITYRREDMP 1000 
C128      YRGPEPSHIDQVMMSVSDNDQALIKVLLRQNRRPELGDKFSSRHGQKGVCGIIVKQEDMP 932 
           *..* . :***:::..::.  ::** :* .: *::****:*******. **  ::**** 
 
Rpb2      FTAEGIVPDLIINPHAIPSRMTVAHLIECLLSKVAALSGNEGDASPFTDITVEGISKLLR 1060 
C128      FNDQGIVPDIIMNPHGFPSRMTVGKMIELISGKAGVLNGTLEYGTCFGGSKLEDMSKILV 992 
          *. :*****:*:***.:******.::** : .*...*.*.   .: * . .:*.:**:*  
 
Rpb2      EHGYQSRGFEVMYNGHTGKKLMAQIFFGPTYYQRLRHMVDDKIHARARGPMQVLTRQPVE 1120 
C128      DQGFNYSGKDMLYSGITGECLQAYIFFGPIYYQKLKHMVLDKMHARARGPRAVLTRQPTE 1052 
          ::*::  * :::*.* **: * * ***** ***:*:*** **:*******  ******.* 
 
Rpb2      GRSRDGGLRFGEMERDCMIAHGAASFLKERLMEASDAFRVHICGICGLMTVIAKLNHNQF 1180 
C128      GRSRDGGLRLGEMERDCVIAYGASQLLLERLMISSDAFEVDVCDKCGLMGYSG------- 1105 
          *********:*******:**:**:.:* **** :****.*.:*. ****   .        
 
Rpb2      ECKGCDNKIDIYQIHIPYAAKLLFQELMAMNITPRLYTDRSRDF 1224 
C128      WCTTCKSAENIIKMTIPYAAKLLFQELLSMNIAPRLRLEDIFQQ 1149 
           *. *..  :* :: ************::***:***  :   :  
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Rpb11-AC19 (Rpc9) 
 
Rpb11      ---------------------MNAPDRFELFLLGEGES---------KLKIDPDTKAPNA 30 
 AC19      MTEDIEQKKTATEVTPQEPKHIQEEEEQDVDMTGDEEQEEEPDREKIKLLTQATSEDGTS 60 
                                ::  :. :: : *: *.         **  :. ::  .: 
 
Rpb11      VVITFEKEDHTLGNLIRAELLNDRKVLFAAYKVEHPFFARFKLRIQTTEGYDPKDALKNA 90 
 AC19      ASFQIVEEDHTLGNALRYVIMKNPDVEFCGYSIPHPSENLLNIRIQTYGETTAVDALQKG 120 
           . : : :******* :*  :::: .* *..*.: **    :::****     . ***::. 
 
Rpb11      CNSIINKLGALKTNFETEWNLQTLAADDAF 120 
 AC19      LKDLMDLCDVVESKFTEKIKSM-------- 142 
            :.:::  ..::::*  : :  
 
 
 
Rpb3-AC40 (Rpc5)  
 
Rpb3      ----------------------MSEEGP------------QVKIREASKDNVDFILSNVD 26 
AC40      MSNIVGIEYNRVTNTTSTDFPGFSKDAENEWNVEKFKKDFEVNISSLDAREANFDLINID 60 
                                :*::.             :*:* . .  :.:* * *:* 
 
Rpb3      LAMANSLRRVMIAEIPTLAIDSVEVETNTTVLADEFIAHRLGLIPLQSMDIEQLEYSRDC 86 
AC40      TSIANAFRRIMISEVPSVAAEYVYFFNNTSVIQDEVLAHRIGLVPLK-VDPDMLTWVDSN 119 
           ::**::**:**:*:*::* : * . .**:*: **.:***:**:**:::* : * :  .  
 
Rpb3      FCED--HCDKCSVVLTLQAFGESE--------------STTNVYSKDLVIVSNLMGRNIG 130 
AC40      LPDDEKFTDENTIVLSLNVKCTRNPDAPKGSTDPKELYNNAHVYARDLKFEPQGRQSTTF 179 
          : :*  . *: ::**:*:.    :              ..::**::** : .:    .   
 
Rpb3      HPIIQDKEGNGVLICKLRKGQELKLTCVAKKGIAKEHAKWGPAAAIEFEYDPWNKLKH-- 188 
AC40      ADCPVVPADPDILLAKLRPGQEISLKAHCILGIGGDHAKFSPVSTASYRLLPQINILQPI 239 
                  . .:*:.*** ***:.*.. .  **. :***:.*.:: .:.  *  :: :   
 
Rpb3      ----------------------TDYWYEQDSAKEWPQSKNCEYEDPPNEGDPFDYKAQAD 226 
AC40      KGESARRFQKCFPPGVIGIDEGSDEAYVKDARKDTVSREVLRYEEFADK---VKLGRVRN 296 
                                :*  * :*: *:  . :  .**: .::.....     : 
 
Rpb3      TFYMNVESVGSIPVDQVVVRGIDTLQKKVASIL-LALTQMDQDKVNFASGDNNTASNMLG 285 
AC40      HFIFNVESAGAMTPEEIFFKSVRILKNKAEYLKNCPITQ--------------------- 335 
           * :****.*::. :::..:.:  *::*.  :   .:*** :*  :  :. : *..:    
 
Rpb3      SNEDVMMTGAEQDPYSNASQMGNTGSGGYDNAW 318 	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VI.3 Cloning and expression of Rrn7 	  
The TFIIB homolog Rrn7 from different yeast species was cloned into vectors 
pET21/28 (Novagen) using restriction enzymes or by homologous 
recombination using the In-Fusion cloning systen (Clontech) and vectors 
pOPINE and pOPINF (Berrow et al., 2007). Expression was tested by 
induction with IPTG for 3h at 37°C or overnight at 18°C, full-length Rrn7 from 
S.cerevisiae was also expressed in auto-inducing medium and LSSB medium. 
 
Table S1. Cloning and expression of Rrn7 
Organism Construct Domains Vector Expression 
S. cerevisiae 1-514 full-length pET21 no expression 
S. cerevisiae 1-514 full-length pET28 Ok, but massive  
DnaK contamination 
S. cerevisiae 63-514 Cyclin 1+2, C-term. pET21 insoluble 
S. cerevisiae 63-514 Cyclin 1+2, C-term. pET28 insoluble 
S. cerevisiae 63-300 Cyclin 1+2 pET28 no clones 
S. cerevisiae 63-175 Cyclin 1 pET28 no expression 
S. cerevisiae 175-300 Cyclin 2 pET28 no expression 
S. cerevisiae 175-514 Cyclin 2, C-term. pET28 insoluble 
S. cerevisiae 300-514 C-term. pET28 insoluble 
S. cerevisiae 1-514 full length pOPINE insoluble 
S. cerevisiae 1-514 full length pOPINF insoluble 
S. cerevisiae 1-281 Zn, Cyclin 1+2 pOPINE insoluble 
S. cerevisiae 1-281 Zn, Cyclin 1+2 pOPINF insoluble 
S. cerevisiae 63-281 Cyclin 1+2 pOPINE no expression 
S. cerevisiae 63-281 Cyclin 1+2 pOPINF no expression 
S. cerevisiae 69-281 Cyclin 1+2 pOPINE no expression 
S. cerevisiae 69-281 Cyclin 1+2 pOPINF no expression 
S.pombe 1-537 full-legth pET28 no expression 
S. pombe 1-537 full length pOPINE insoluble 
S. pombe 1-537 full length pOPINF no expression 
S. pombe 1-307 Zn, Cyclin 1+2 pOPINE insoluble 
S. pombe 1-307 Zn, Cyclin 1+2 pOPINF insoluble 
S. pombe 54-307 Cyclin 1+2 pOPINE no expression 
S. pombe 54-307 Cyclin 1+2 pOPINF insoluble 
S. pombe 54-537 Cyclin 1+2, C-term. pOPINE insoluble 
S. pombe 54-537 Cyclin 1+2, C-term. pOPINF no expression 
S. pombe 325-537 C-terminus pOPINE no clones 
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S. pombe 325-537 C-terminus pOPINF insoluble 
C. glabrata 1-543 full-length pET28 no expression 
C. glabrata 1-543 full length pOPINE insoluble 
C. glabrata 1-543 full length pOPINF no expression 
C. glabrata 1-322 Zn, Cyclin 1+2 pOPINE no clones 
C. glabrata 1-322 Zn, Cyclin 1+2 pOPINF no expression 
C. glabrata 75-322 Cyclin 1+2 pOPINE insoluble 
C. glabrata 75-322 Cyclin 1+2 pOPINF insoluble 
C. glabrata 75-543 Cyclin 1+2, C-term. pOPINE no expression 
C. glabrata 75-543 Cyclin 1+2, C-term. pOPINF insoluble 
C. glabrata 340-543 C-terminus pOPINE insoluble 
C. glabrata 340-543 C-terminus pOPINF no expression 
A. gossypii 1-516 full length pOPINE no clones 
A. gossypii 1-516 full length pOPINF insoluble 
A. gossypii 1-299 Zn, Cyclin 1+2 pOPINE no expression 
A. gossypii 1-299 Zn, Cyclin 1+2 pOPINF insoluble 
A. gossypii 67-299 Cyclin 1+2 pOPINE insoluble 
A. gossypii 67-299 Cyclin 1+2 pOPINF insoluble 
A. gossypii 67-516 Cyclin 1+2, C-term. pOPINE insoluble 
A. gossypii 67-516 Cyclin 1+2, C-term. pOPINF insoluble 
A. gossypii 314-516 C-terminus pOPINE insoluble 
A. gossypii 314-516 C-terminus pOPINF no clones 
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°C degree Celsius 
6-FAM 6-carboxy-fluoresceine 
Å angstrom 
Amp ampicillin 
ATP adenosine triphosphate 
bp base pair 
Cα Carbon atom at α-position of 
the peptide chain  
Cam chloramphenicol 
CE core element 
CF core factor 
CID collision induced dissociation 
CV column volume 
Da Dalton 
DNA Deoxyribonucleic acid 
DSS di-succimidyl suberate 
DTT dithiothreitol 
E.c. Escherichia coli 
EC elongation complex 
EM electron microscopy 
ETS external transcribed spacer 
eV electron volt  
FSC Fourier shell correlation 
g g-force 
G418 geneticin 
GLRF generally locked rotation 
function 
GTF general transcription factor 
GTP guanosin triphosphate 
HEPES 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid  
IGS intergenic spacer 
IPTG isopropyl β-D-1-
thiogalactopyranoside 
Kan kanamycin 
LB Luria-Bertani medium 
LC-
MS/MS 
liquid chromatography tandem 
mass spectrometry 
m/z mass to charge ratio 
mRNA messenger RNA 
NCS non-crystallographic symmetry 
NiNTA nickel-nitrilotriacetic acid  
NOR nucleolar oragnizer region 	  
	  	  	  
NTP nucleoside triphosphate 
OD600 optical density at 600 nm 
wavelength 
PAGE polyacrylamid gel 
electrophoresis 
PDB protein data bank 
PEG polyethylen glycol 
PI protease inhibitor mix 
Pol RNA polymerase 
ppm parts per million 
RNA Ribonucleic acid 
rRNA ribosomal RNA 
S.c. Saccharomyces cerevisiae 
S.p. Schizosaccharomyces pombe 
SDC synthetic dextrose complete 
medium 
SDS sodium dodecyl sulfate 
SEC size exclusion chromatography 
SINES short interspersed nuclear 
elements  
SLS Swiss Light Source 
snoRNP small nucleolar 
ribonucleoprotein  
SOB super optimal broth medium 
TAF TATA-box associated factor 
TB terrific broth medium 
TCEP tris(2-carboxyethyl)phosphine 
Tet tetracyklin 
TOR target of rapamycin 
tRNA transfer RNA 
UAF upstream activating factor 
UBF upstream binding factor 
UE upstream element 
v/v volume per volume 
w/v weight per volume 
YPD yeast extract peptone dextrose 
medium 	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